UNITED STATES
SECURITIES AND EXCHANGE
COMMISSION

Washington, D.C. 20549

OMB APPROVAL
  OMB Number:  3235-0582
  Expires:  July 31, 2024
  Estimated average burden
  hours per response........4

 

FORM N-PX

 

ANNUAL REPORT OF PROXY VOTING RECORD OF REGISTERED
MANAGEMENT INVESTMENT COMPANY

 

Investment Company Act file number  811- 06565

 

Tekla Healthcare Opportunites Fund 

(Exact name of registrant as specified in charter)

 

100 Federal Street, 19th Floor, Boston, MA   02110
(Address of principal executive offices)   (Zip code)

 

Laura Woodward 

Tekla Healthcare Opportunities Fund 

100 Federal Street, 19th Floor, Boston MA 02110 

(Name and address of agent for service)

 

Registrant’s telephone number, including area code:  617-772-8500

 

Date of fiscal year end:  September 30

 

Date of reporting period:  7/1/21-6/30/22

 

Form N-PX is to be used by a registered management investment company, other than a small business investment company registered on Form N-5 (ss.ss. 239.24 and 274.5 of this chapter), to file reports with the Commission, no later than August 31 of each year, containing the registrant’s proxy voting record for the most recent twelve-month period ended June 30, pursuant to section 30 of the Investment Company Act of 1940 and rule 30b1-4 thereunder (17 CFR 270.30b1-4). The Commission may use the information provided on Form N-PX in its regulatory, disclosure review, inspection, and policymaking roles.

 

A registrant is required to disclose the information specified by Form N-PX, and the Commission will make this information public. A registrant is not required to respond to the collection of information contained in Form N-PX unless the Form displays a currently valid Office of Management and Budget (“OMB”) control number. Please direct comments concerning the accuracy of the information collection burden estimate and any suggestions for reducing the burden to the Secretary, Securities and Exchange Commission, 450 Fifth Street, NW, Washington, DC 20549-0609. The OMB has reviewed this collection of information under the clearance requirements of 44 U.S.C. ss. 3507.

 

 

 

 

 

 

Item 1. Proxy Voting Record.

 

 

 

 

Vote Summary

 

1LIFE HEALTHCARE, INC.

 

Security 68269G107 Meeting Type Special
Ticker Symbol ONEM Meeting Date 27-Aug-2021
Record Date 13-Jul-2021    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1.   To approve the issuance of shares of common stock, $0.001 par value per share, of 1Life Healthcare, Inc. to stockholders of Iora Health, Inc. in connection with the merger contemplated by the Agreement and Plan of Merger, dated June 6, 2021, among 1Life Healthcare, Inc., SB Merger Sub, Inc., Iora Health, Inc. and Fortis Advisors LLC, solely in its capacity as the representative of the stockholders of Iora.   Management   For   For  
2.   To approve adjournments of the 1Life special meeting, if necessary and appropriate, to solicit additional proxies if there are not sufficient votes to approve the 1Life stock issuance proposal.   Management   For   For  

 

1LIFE HEALTHCARE, INC.

 

Security 68269G107 Meeting Type Annual
Ticker Symbol ONEM Meeting Date 02-Jun-2022
Record Date 04-Apr-2022    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1.   DIRECTOR   Management          
    1. Paul R. Auvil       For   For  
    2. Mark S. Blumenkranz, MD       For   For  
    3. Kalen F. Holmes, Ph.D.       For   For  
2.   To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2022.   Management   For   For  
3.   To approve, on a non-binding advisory basis, the compensation of our named executive officers.   Management   For   For  
4.   To approve, on a non-binding advisory basis, the frequency of future non-binding stockholder advisory votes on the compensation of our named executive officers.   Management   1 Year   For  

 

 

 

 

ABBOTT LABORATORIES

 

Security 002824100 Meeting Type Annual
Ticker Symbol ABT Meeting Date 29-Apr-2022
Record Date 02-Mar-2022    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1.   DIRECTOR   Management          
    1. R. J. Alpern       For   For  
    2. S. E. Blount       For   For  
    3. R. B. Ford       For   For  
    4. P. Gonzalez       For   For  
    5. M. A. Kumbier       For   For  
    6. D. W. McDew       For   For  
    7. N. McKinstry       For   For  
    8. W. A. Osborn       For   For  
    9. M. F. Roman       For   For  
    10. D. J. Starks       For   For  
    11. J. G. Stratton       For   For  
    12. G. F. Tilton       For   For  
2.   Ratification of Ernst & Young LLP As Auditors   Management   For   For  
3.   Say on Pay - An Advisory Vote on the Approval of Executive Compensation   Management   For   For  
4.   Shareholder Proposal - Special Shareholder Meeting Threshold   Shareholder   Against   For  
5.   Shareholder Proposal - Independent Board Chairman   Shareholder   For   Against  
6.   Shareholder Proposal - Rule 10b5-1 Plans   Shareholder   Against   For  
7.   Shareholder Proposal - Lobbying Disclosure   Shareholder   Against   For  
8.   Shareholder Proposal - Antimicrobial Resistance Report   Shareholder   Against   For  

 

 

 

 

ABBVIE INC.

 

Security 00287Y109 Meeting Type Annual
Ticker Symbol ABBV Meeting Date 06-May-2022
Record Date 07-Mar-2022    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1.   DIRECTOR   Management          
    1. William H.L. Burnside       For   For  
    2. Thomas C. Freyman       For   For  
    3. Brett J. Hart       For   For  
    4. Edward J. Rapp       For   For  
2.   Ratification of Ernst & Young LLP as AbbVie's independent registered public accounting firm for 2022   Management   For   For  
3.   Say on Pay - An advisory vote on the approval of executive compensation   Management   For   For  
4.   Approval of a management proposal regarding amendment of the certificate of incorporation to eliminate supermajority voting   Management   For   For  
5.   Stockholder Proposal - to Adopt a Policy to Require Independent Chairman   Shareholder   For   Against  
6.   Stockholder Proposal - to Seek Shareholder Approval of Certain Termination Pay Arrangements   Shareholder   Against   For  
7.   Stockholder Proposal - to Issue a Report on Board Oversight of Competition Practices   Shareholder   Against   For  
8.   Stockholder Proposal - to Issue an Annual Report on Political Spending   Shareholder   Against   For  

 

 

 

 

ACADIA HEALTHCARE COMPANY, INC.

 

Security 00404A109 Meeting Type Annual
Ticker Symbol ACHC Meeting Date 19-May-2022
Record Date 24-Mar-2022    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1A.   Election of Director: Jason R. Bernhard   Management   For   For  
1B.   Election of Director: William F. Grieco   Management   For   For  
1C.   Election of Director: Reeve B. Waud   Management   For   For  
2.   Advisory vote on the compensation of the Company's named executive officers as presented in the Proxy Statement.   Management   For   For  
3.   Ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2022.   Management   For   For  

 

ADDUS HOMECARE CORPORATION

 

Security 006739106 Meeting Type Annual
Ticker Symbol ADUS Meeting Date 15-Jun-2022
Record Date 22-Apr-2022    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1.   DIRECTOR   Management          
    1. Esteban López, M.D.       For   For  
    2. Jean Rush       For   For  
    3. Susan T. Weaver MD FACP       For   For  
2.   To ratify the appointment of PricewaterhouseCoopers LLP, an independent registered public accounting firm, as our independent auditor for the fiscal year ending December 31, 2022.   Management   For   For  
3.   To approve, on an advisory, non-binding basis, the compensation of the named executive officers.   Management   For   For  

 

 

 

 

AGILENT TECHNOLOGIES, INC.

 

Security 00846U101 Meeting Type Annual
Ticker Symbol A Meeting Date 16-Mar-2022
Record Date 18-Jan-2022    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1.1   Election of Director for a three-year term: Hans E. Bishop   Management   For   For  
1.2   Election of Director for a three-year term: Otis W. Brawley, M.D.   Management   For   For  
1.3   Election of Director for a three-year term: Mikael Dolsten, M.D., Ph.D.   Management   For   For  
2.   To approve, on a non-binding advisory basis, the compensation of our named executive officers.   Management   For   For  
3.   To ratify the Audit and Finance Committee's appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm.   Management   For   For  
4.   To vote on a stockholder proposal regarding the right to call a special meeting, if properly presented at the meeting.   Management   Against   For  

 

ALERISLIFE, INC.

 

Security 33832D205 Meeting Type Annual
Ticker Symbol ALR Meeting Date 07-Jun-2022
Record Date 22-Mar-2022    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1.1   Election of Director: Jennifer B. Clark (for Managing Director in Group III)   Management   For   For  
1.2   Election of Director: Bruce M. Gans, M.D. (for Independent Director in Group III)   Management   For   For  
1.3   Election of Director: Michael E. Wagner, M.D. (for Independent Director in Group III)   Management   For   For  
2.   Approval of the Second Amended and Restated 2014 Equity Compensation Plan.   Management   For   For  
3.   Ratification of the appointment of Deloitte & Touche LLP as independent auditors to serve for the 2022 fiscal year.   Management   For   For  

 

 

 

 

ALIGN TECHNOLOGY, INC.

 

Security 016255101 Meeting Type Annual
Ticker Symbol ALGN Meeting Date 18-May-2022
Record Date 23-Mar-2022    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1a.   Election of Director: Kevin J. Dallas   Management   For   For  
1b.   Election of Director: Joseph M. Hogan   Management   For   For  
1c.   Election of Director: Joseph Lacob   Management   For   For  
1d.   Election of Director: C. Raymond Larkin, Jr.   Management   For   For  
1e.   Election of Director: George J. Morrow   Management   For   For  
1f.   Election of Director: Anne M. Myong   Management   For   For  
1g.   Election of Director: Andrea L. Saia   Management   For   For  
1h.   Election of Director: Greg J. Santora   Management   For   For  
1i.   Election of Director: Susan E. Siegel   Management   For   For  
1j.   Election of Director: Warren S. Thaler   Management   For   For  
2.   RATIFICATION OF APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTANTS: Proposal to ratify the appointment of PricewaterhouseCoopers LLP as Align Technology, Inc.'s independent registered public accountants for the fiscal year ending December 31, 2022.   Management   For   For  
3.   ADVISORY VOTE ON NAMED EXECUTIVES COMPENSATION: Consider an Advisory Vote to Approve the Compensation of our Named Executive Officers.   Management   For   For  

 

 

 

 

AMGEN, INC.

 

Security 031162100 Meeting Type Annual
Ticker Symbol AMGN Meeting Date 17-May-2022
Record Date 18-Mar-2022    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1A.   Election of Director for a term of expiring at the 2023 annual meeting: Dr. Wanda M. Austin   Management   For   For  
1B.   Election of Director for a term of expiring at the 2023 annual meeting: Mr. Robert A. Bradway   Management   For   For  
1C.   Election of Director for a term of expiring at the 2023 annual meeting: Dr. Brian J. Druker   Management   For   For  
1D.   Election of Director for a term of expiring at the 2023 annual meeting: Mr. Robert A. Eckert   Management   For   For  
1E.   Election of Director for a term of expiring at the 2023 annual meeting: Mr. Greg C. Garland   Management   For   For  
1F.   Election of Director for a term of expiring at the 2023 annual meeting: Mr. Charles M. Holley, Jr.   Management   For   For  
1G.   Election of Director for a term of expiring at the 2023 annual meeting: Dr. S. Omar Ishrak   Management   For   For  
1H.   Election of Director for a term of expiring at the 2023 annual meeting: Dr. Tyler Jacks   Management   For   For  
1I.   Election of Director for a term of expiring at the 2023 annual meeting: Ms. Ellen J. Kullman   Management   For   For  
1J.   Election of Director for a term of expiring at the 2023 annual meeting: Ms. Amy E. Miles   Management   For   For  
1K.   Election of Director for a term of expiring at the 2023 annual meeting: Dr. Ronald D. Sugar   Management   For   For  
1L.   Election of Director for a term of expiring at the 2023 annual meeting: Dr. R. Sanders Williams   Management   For   For  
2.   Advisory vote to approve our executive compensation.   Management   For   For  
3.   To ratify the selection of Ernst & Young LLP as our independent registered public accountants for the fiscal year ending December 31, 2022.   Management   For   For  

 

 

 

 

AMN HEALTHCARE SERVICES, INC.

 

Security 001744101 Meeting Type Annual
Ticker Symbol AMN Meeting Date 06-May-2022
Record Date 14-Mar-2022    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1A.   Election of Director: Jorge A. Caballero   Management   For   For  
1B.   Election of Director: Mark G. Foletta   Management   For   For  
1C.   Election of Director: Teri G. Fontenot   Management   For   For  
1D.   Election of Director: R. Jeffrey Harris   Management   For   For  
1E.   Election of Director: Daphne E. Jones   Management   For   For  
1F.   Election of Director: Martha H. Marsh   Management   For   For  
1G.   Election of Director: Susan R. Salka   Management   For   For  
1H.   Election of Director: Sylvia Trent-Adams   Management   For   For  
1I.   Election of Director: Douglas D. Wheat   Management   For   For  
2.   To approve, by non-binding advisory vote, the compensation of the Company's named executive officers.   Management   For   For  
3.   To approve the AMN Healthcare Employee Stock Purchase Plan.   Management   For   For  
4.   To ratify the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2022.   Management   For   For  
5.   A shareholder proposal entitled: "Special Shareholder Meeting Improvement".   Shareholder   Against   For  

 

 

 

 

ANTHEM, INC.

 

Security 036752103 Meeting Type Annual
Ticker Symbol ANTM Meeting Date 18-May-2022
Record Date 17-Mar-2022    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1.1   Election of Director: Susan D. DeVore   Management   For   For  
1.2   Election of Director: Bahija Jallal   Management   For   For  
1.3   Election of Director: Ryan M. Schneider   Management   For   For  
1.4   Election of Director: Elizabeth E. Tallett   Management   For   For  
2.   Advisory vote to approve the compensation of our named executive officers.   Management   For   For  
3.   To ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm for 2022.   Management   For   For  
4.   To approve an amendment to our Articles of Incorporation to change our name to Elevance Health, Inc.   Management   For   For  
5.   Shareholder proposal to prohibit political funding.   Shareholder   Against   For  
6.   Shareholder proposal requesting a racial impact audit and report.   Shareholder   Against   For  

 

 

 

 

ASSERTIO HOLDINGS, INC.

 

Security 04546C205 Meeting Type Annual
Ticker Symbol ASRT Meeting Date 04-May-2022
Record Date 28-Mar-2022    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1.1   Election of Director to serve until the 2023 Annual Meeting of Stockholders: Heather L. Mason   Management   For   For  
1.2   Election of Director to serve until the 2023 Annual Meeting of Stockholders: William T. McKee   Management   For   For  
1.3   Election of Director to serve until the 2023 Annual Meeting of Stockholders: Daniel A. Peisert   Management   For   For  
1.4   Election of Director to serve until the 2023 Annual Meeting of Stockholders: Peter D. Staple   Management   For   For  
1.5   Election of Director to serve until the 2023 Annual Meeting of Stockholders: James L. Tyree   Management   For   For  
2.   To approve an amendment and restatement of Assertio's Amended and Restated 2014 Omnibus Incentive Plan, including an increase in the number of shares available for issuance thereunder.   Management   For   For  
3.   To approve, on an advisory basis, the compensation of Assertio's named executive officers.   Management   For   For  
4.   To ratify the appointment of Grant Thornton LLP as Assertio's independent registered public accounting firm for the fiscal year ending December 31, 2022.   Management   For   For  

 

 

 

 

ASTRAZENECA PLC

 

Security 046353108 Meeting Type Annual
Ticker Symbol AZN Meeting Date 29-Apr-2022
Record Date 07-Apr-2022    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1.   To receive the Company's Accounts, the Reports of the Directors and Auditor and the Strategic Report for the year ended 31 December 2021   Management   For   For  
2.   To confirm dividends   Management   For   For  
3.   To reappoint PricewaterhouseCoopers LLP as Auditor   Management   For   For  
4.   To authorise the Directors to agree the remuneration of the Auditor   Management   For   For  
5A.   Re-election of Director: Leif Johansson   Management   For   For  
5B.   Re-election of Director: Pascal Soriot   Management   For   For  
5C.   Election of Director: Aradhana Sarin   Management   For   For  
5D.   Re-election of Director: Philip Broadley   Management   For   For  
5E.   Re-election of Director: Euan Ashley   Management   For   For  
5F.   Re-election of Director: Michel Demaré   Management   For   For  
5G.   Re-election of Director: Deborah DiSanzo   Management   For   For  
5H.   Re-election of Director: Diana Layfield   Management   For   For  
5I.   Re-election of Director: Sheri McCoy   Management   For   For  
5J.   Re-election of Director: Tony Mok   Management   For   For  
5K.   Re-election of Director: Nazneen Rahman   Management   For   For  
5L.   Election of Director: Andreas Rummelt   Management   For   For  
5M.   Re-election of Director: Marcus Wallenberg   Management   For   For  
6.   To approve the Annual Report on Remuneration for the year ended 31 December 2021   Management   For   For  
7.   To authorise limited political donations   Management   For   For  
8.   To authorise the Directors to allot shares   Management   For   For  
9.   To authorise the Directors to disapply pre-emption rights (Special Resolution)   Management   For   For  
10.   To authorise the Directors to further disapply pre-emption rights for acquisitions and specified capital investments (Special Resolution)   Management   For   For  
11.   To authorise the Company to purchase its own shares (Special Resolution)   Management   For   For  
12.   To reduce the notice period for general meetings (Special Resolution)   Management   For   For  
13.   To extend the AstraZenca PLC 2012 Savings Related Share Option Scheme   Management   For   For  

 

 

 

BECTON, DICKINSON AND COMPANY              

 

Security 075887109 Meeting Type Annual
Ticker Symbol BDX Meeting Date 25-Jan-2022
Record Date 06-Dec-2021    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1A.   Election of Director: Catherine M. Burzik   Management   For   For  
1B.   Election of Director: Carrie L. Byington   Management   For   For  
1C.   Election of Director: R. Andrew Eckert   Management   For   For  
1D.   Election of Director: Claire M. Fraser   Management   For   For  
1E.   Election of Director: Jeffrey W. Henderson   Management   For   For  
1F.   Election of Director: Christopher Jones   Management   For   For  
1G.   Election of Director: Marshall O. Larsen   Management   For   For  
1H.   Election of Director: David F. Melcher   Management   For   For  
1I.   Election of Director: Thomas E. Polen   Management   For   For  
1J.   Election of Director: Claire Pomeroy   Management   For   For  
1K.   Election of Director: Timothy M. Ring   Management   For   For  
1L.   Election of Director: Bertram L. Scott   Management   For   For  
2.   Ratification of the selection of the independent registered public accounting firm.   Management   For   For  
3.   Advisory vote to approve named executive officer compensation.   Management   For   For  
4.   A shareholder proposal seeking to lower the ownership threshold required to call a special shareholders meeting, if properly presented at the meeting.   Shareholder   Against   For  

 

 

 

 

BIO-TECHNE CORP

 

Security 09073M104 Meeting Type Annual
Ticker Symbol TECH Meeting Date 28-Oct-2021
Record Date 03-Sep-2021    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1.   To set the number of Directors at nine.   Management   For   For  
2A.   Election of Director: Robert V. Baumgartner   Management   For   For  
2B.   Election of Director: Julie L. Bushman   Management   For   For  
2C.   Election of Director: John L. Higgins   Management   For   For  
2D.   Election of Director: Joseph D. Keegan   Management   For   For  
2E.   Election of Director: Charles R. Kummeth   Management   For   For  
2F.   Election of Director: Roeland Nusse   Management   For   For  
2G.   Election of Director: Alpna Seth   Management   For   For  
2H.   Election of Director: Randolph Steer   Management   For   For  
2I.   Election of Director: Rupert Vessey   Management   For   For  
3.   Cast a non-binding vote on named executive officer compensation.   Management   For   For  
4.   Ratify the appointment of the Company's independent registered public accounting firm for the 2022 fiscal year.   Management   For   For  

 

BIOGEN, INC.

 

Security 09062X103 Meeting Type Annual
Ticker Symbol BIIB Meeting Date 15-Jun-2022
Record Date 21-Apr-2022    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1a.   Election of Director to serve for a one-year term extending until the 2023 Annual Meeting: Alexander J. Denner   Management   For   For  
1b.   Election of Director to serve for a one-year term extending until the 2023 Annual Meeting: Caroline D. Dorsa   Management   For   For  
1c.   Election of Director to serve for a one-year term extending until the 2023 Annual Meeting: Maria C. Freire   Management   For   For  
1d.   Election of Director to serve for a one-year term extending until the 2023 Annual Meeting: William A. Hawkins   Management   For   For  
1e.   Election of Director to serve for a one-year term extending until the 2023 Annual Meeting: William D. Jones   Management   For   For  
1f.   Election of Director to serve for a one-year term extending until the 2023 Annual Meeting: Jesus B. Mantas   Management   For   For  
1g.   Election of Director to serve for a one-year term extending until the 2023 Annual Meeting: Richard C. Mulligan   Management   For   For  
1h.   Election of Director to serve for a one-year term extending until the 2023 Annual Meeting: Stelios Papadopoulos   Management   For   For  
1i.   Election of Director to serve for a one-year term extending until the 2023 Annual Meeting: Eric K. Rowinsky   Management   For   For  
1j.   Election of Director to serve for a one-year term extending until the 2023 Annual Meeting: Stephen A. Sherwin   Management   For   For  
1k.   Election of Director to serve for a one-year term extending until the 2023 Annual Meeting: Michel Vounatsos   Management   For   For  
2.   To ratify the selection of PricewaterhouseCoopers LLP as Biogen Inc.'s independent registered public accounting firm for the fiscal year ending December 31, 2022.   Management   For   For  
3.   Say on Pay - To approve an advisory vote on executive compensation.   Management   For   For  

 

 

 

 

BOSTON SCIENTIFIC CORPORATION

 

Security 101137107 Meeting Type Annual
Ticker Symbol BSX Meeting Date 05-May-2022
Record Date 11-Mar-2022    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1A.   Election of Director: Nelda J. Connors   Management   For   For  
1B.   Election of Director: Charles J. Dockendorff   Management   For   For  
1C.   Election of Director: Yoshiaki Fujimori   Management   For   For  
1D.   Election of Director: Donna A. James   Management   For   For  
1E.   Election of Director: Edward J. Ludwig   Management   For   For  
1F.   Election of Director: Michael F. Mahoney   Management   For   For  
1G.   Election of Director: David J. Roux   Management   For   For  
1H.   Election of Director: John E. Sununu   Management   For   For  
1I.   Election of Director: David S. Wichmann   Management   For   For  
1J.   Election of Director: Ellen M. Zane   Management   For   For  
2.   To approve, on a non-binding, advisory basis, named executive officer compensation.   Management   For   For  
3.   To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the 2022 fiscal year.   Management   For   For  
4.   To approve an amendment and restatement of our 2006 Global Employee Stock Ownership Plan (to be renamed as our Employee Stock Purchase Plan), as previously amended and restated, including a request for 10,000,000 additional shares.   Management   For   For  

 

 

 

 

BRISTOL-MYERS SQUIBB COMPANY

 

Security 110122108 Meeting Type Annual
Ticker Symbol BMY Meeting Date 03-May-2022
Record Date 14-Mar-2022    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1A)   Election of Director: Peter J. Arduini   Management   For   For  
1B)   Election of Director: Giovanni Caforio, M.D.   Management   For   For  
1C)   Election of Director: Julia A. Haller, M.D.   Management   For   For  
1D)   Election of Director: Manuel Hidalgo Medina, M.D., Ph.D.   Management   For   For  
1E)   Election of Director: Paula A. Price   Management   For   For  
1F)   Election of Director: Derica W. Rice   Management   For   For  
1G)   Election of Director: Theodore R. Samuels   Management   For   For  
1H)   Election of Director: Gerald L. Storch   Management   For   For  
1I)   Election of Director: Karen H. Vousden, Ph.D.   Management   For   For  
1J)   Election of Director: Phyllis R. Yale   Management   For   For  
2.   Advisory Vote to Approve the Compensation of our Named Executive Officers.   Management   For   For  
3.   Ratification of the Appointment of an Independent Registered Public Accounting Firm.   Management   For   For  
4.   Shareholder Proposal to Lower the Ownership Threshold for Special Shareholder Meetings to 10%.   Shareholder   Against   For  
5.   Shareholder Proposal on the Adoption of a Board Policy that the Chairperson of the Board be an Independent Director.   Shareholder   For   Against  

 

 

 

 

CATALENT, INC.

 

Security 148806102 Meeting Type Annual
Ticker Symbol CTLT Meeting Date 28-Oct-2021
Record Date 03-Sep-2021    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1A.   Election of Director: Madhavan Balachandran   Management   For   For  
1B.   Election of Director: Michael J. Barber   Management   For   For  
1C.   Election of Director: J. Martin Carroll   Management   For   For  
1D.   Election of Director: John Chiminski   Management   For   For  
1E.   Election of Director: Rolf Classon   Management   For   For  
1F.   Election of Director: Rosemary A. Crane   Management   For   For  
1G.   Election of Director: John Greisch   Management   For   For  
1H.   Election of Director: Christa Kreuzburg   Management   For   For  
1I.   Election of Director: Gregory T. Lucier   Management   For   For  
1J.   Election of Director: Donald E. Morel, Jr.   Management   For   For  
1K.   Election of Director: Jack Stahl   Management   For   For  
2.   Ratification of Appointment of Independent Auditor for Fiscal 2022.   Management   For   For  
3.   Advisory Vote to Approve Our Executive Compensation (Say-on-Pay).   Management   For   For  
4.   Advisory Vote on the Frequency of Advisory Votes in Respect of Executive Compensation.   Management   1 Year   For  
5.   Amend our Certificate of Incorporation to Remove the Limitation on Calling Shareholder Special Meetings.   Management   For   For  
6.   Amend our Certificate of Incorporation to Add a Federal Forum Selection Provision.   Management   For   For  
7.   Amend and Restate our Certificate of Incorporation to (i) Eliminate the Supermajority Vote Requirement for Amendments and (ii) Make Non-Substantive and Conforming Changes.   Management   For   For  

 

 

 

 

CHARLES RIVER LABORATORIES INTL., INC.

 

Security 159864107 Meeting Type Annual
Ticker Symbol CRL Meeting Date 10-May-2022
Record Date 21-Mar-2022    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1A.   Election of Director: James C. Foster   Management   For   For  
1B.   Election of Director: Nancy C. Andrews   Management   For   For  
1C.   Election of Director: Robert Bertolini   Management   For   For  
1D.   Election of Director: Deborah T. Kochevar   Management   For   For  
1E.   Election of Director: George Llado, Sr.   Management   For   For  
1F.   Election of Director: Martin W. MacKay   Management   For   For  
1G.   Election of Director: George E. Massaro   Management   For   For  
1H.   Election of Director: C. Richard Reese   Management   For   For  
1I.   Election of Director: Richard F. Wallman   Management   For   For  
1J.   Election of Director: Virginia M. Wilson   Management   For   For  
2.   Advisory approval of 2021 Executive Compensation   Management   For   For  
3.   Ratification of PricewaterhouseCoopers LLC as independent registered accounting public firm for 2022   Management   For   For  

 

 

 

 

CIGNA CORPORATION

 

Security 125523100 Meeting Type Annual
Ticker Symbol CI Meeting Date 27-Apr-2022
Record Date 08-Mar-2022    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1A.   Election of Director: David M. Cordani   Management   For   For  
1B.   Election of Director: William J. DeLaney   Management   For   For  
1C.   Election of Director: Eric J. Foss   Management   For   For  
1D.   Election of Director: Elder Granger, MD, MG, USA (Retired)   Management   For   For  
1E.   Election of Director: Neesha Hathi   Management   For   For  
1F.   Election of Director: George Kurian   Management   For   For  
1G.   Election of Director: Kathleen M. Mazzarella   Management   For   For  
1H.   Election of Director: Mark B. McClellan, MD, PhD   Management   For   For  
1I.   Election of Director: Kimberly A. Ross   Management   For   For  
1J.   Election of Director: Eric C. Wiseman   Management   For   For  
1K.   Election of Director: Donna F. Zarcone   Management   For   For  
2.   Advisory approval of Cigna's executive compensation.   Management   For   For  
3.   Ratification of the appointment of PricewaterhouseCoopers LLP as Cigna's independent registered public accounting firm for 2022.   Management   For   For  
4.   Shareholder proposal - Special shareholder meeting improvement.   Shareholder   Against   For  
5.   Shareholder proposal - Gender pay gap report.   Shareholder   Against   For  
6.   Shareholder proposal - Political contributions report.   Shareholder   Against   For  

 

 

 

 

COMMUNITY HEALTH SYSTEMS, INC.

 

Security 203668108 Meeting Type Annual
Ticker Symbol CYH Meeting Date 10-May-2022
Record Date 14-Mar-2022    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1A.   Election of Director: Susan W. Brooks   Management   For   For  
1B.   Election of Director: John A. Clerico   Management   For   For  
1C.   Election of Director: Michael Dinkins   Management   For   For  
1D.   Election of Director: James S. Ely III   Management   For   For  
1E.   Election of Director: John A. Fry   Management   For   For  
1F.   Election of Director: Joseph A. Hastings, D.M.D.   Management   For   For  
1G.   Election of Director: Tim L. Hingtgen   Management   For   For  
1H.   Election of Director: Elizabeth T. Hirsch   Management   For   For  
1I.   Election of Director: William Norris Jennings, M.D.   Management   For   For  
1J.   Election of Director: K. Ranga Krishnan, MBBS   Management   For   For  
1K.   Election of Director: Wayne T. Smith   Management   For   For  
1L.   Election of Director: H. James Williams, Ph.D.   Management   For   For  
2.   Proposal to approve on an advisory (non-binding) basis the compensation of the Company's named executive officers.   Management   For   For  
3.   Proposal to ratify the selection of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2022.   Management   For   For  

 

 

 

 

CVS HEALTH CORPORATION

 

Security 126650100 Meeting Type Annual
Ticker Symbol CVS Meeting Date 11-May-2022
Record Date 14-Mar-2022    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1A.   Election of Director: Fernando Aguirre   Management   For   For  
1B.   Election of Director: C. David Brown II   Management   For   For  
1C.   Election of Director: Alecia A. DeCoudreaux   Management   For   For  
1D.   Election of Director: Nancy-Ann M. DeParle   Management   For   For  
1E.   Election of Director: Roger N. Farah   Management   For   For  
1F.   Election of Director: Anne M. Finucane   Management   For   For  
1G.   Election of Director: Edward J. Ludwig   Management   For   For  
1H.   Election of Director: Karen S. Lynch   Management   For   For  
1I.   Election of Director: Jean-Pierre Millon   Management   For   For  
1J.   Election of Director: Mary L. Schapiro   Management   For   For  
1K.   Election of Director: William C. Weldon   Management   For   For  
2.   Ratification of the appointment of our independent registered public accounting firm for 2022.   Management   For   For  
3.   Say on Pay, a proposal to approve, on an advisory basis, the Company's executive compensation.   Management   For   For  
4.   Stockholder proposal for reducing our ownership threshold to request a special stockholder meeting.   Shareholder   Against   For  
5.   Stockholder proposal regarding our independent Board Chair.   Shareholder   For   Against  
6.   Stockholder proposal on civil rights and non- discrimination audit focused on "non-diverse" employees.   Shareholder   Against   For  
7.   Stockholder proposal requesting paid sick leave for all employees.   Shareholder   Against   For  
8.   Stockholder proposal regarding a report on the public health costs of our food business to diversified portfolios.   Shareholder   Against   For  

 

 

 

 

DANAHER CORPORATION

 

Security 235851102 Meeting Type Annual
Ticker Symbol DHR Meeting Date 10-May-2022
Record Date 11-Mar-2022    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1A.   Election of Director to hold office until the 2023 Annual Meeting of Shareholders: Rainer M. Blair   Management   For   For  
1B.   Election of Director to hold office until the 2023 Annual Meeting of Shareholders: Linda Filler   Management   For   For  
1C.   Election of Director to hold office until the 2023 Annual Meeting of Shareholders: Teri List   Management   For   For  
1D.   Election of Director to hold office until the 2023 Annual Meeting of Shareholders: Walter G. Lohr, Jr.   Management   For   For  
1E.   Election of Director to hold office until the 2023 Annual Meeting of Shareholders: Jessica L. Mega, MD, MPH   Management   For   For  
1F.   Election of Director to hold office until the 2023 Annual Meeting of Shareholders: Mitchell P. Rales   Management   For   For  
1G.   Election of Director to hold office until the 2023 Annual Meeting of Shareholders: Steven M. Rales   Management   For   For  
1H.   Election of Director to hold office until the 2023 Annual Meeting of Shareholders: Pardis C. Sabeti, MD, D. PHIL   Management   For   For  
1I.   Election of Director to hold office until the 2023 Annual Meeting of Shareholders: A. Shane Sanders   Management   For   For  
1J.   Election of Director to hold office until the 2023 Annual Meeting of Shareholders: John T. Schwieters   Management   For   For  
1K.   Election of Director to hold office until the 2023 Annual Meeting of Shareholders: Alan G. Spoon   Management   For   For  
1L.   Election of Director to hold office until the 2023 Annual Meeting of Shareholders: Raymond C. Stevens, Ph.D   Management   For   For  
1M.   Election of Director to hold office until the 2023 Annual Meeting of Shareholders: Elias A. Zerhouni, MD   Management   For   For  
2.   To ratify the selection of Ernst & Young LLP as Danaher's independent registered public accounting firm for the year ending December 31, 2022.   Management   For   For  
3.   To approve on an advisory basis the Company's named executive officer compensation.   Management   For   For  
4.   To act upon a shareholder proposal requesting that Danaher amend its governing documents to reduce the percentage of shares required for shareholders to call a special meeting of shareholders from 25% to 10%.   Shareholder   Against   For  

 

 

 

 

 

DENTSPLY SIRONA INC.

 

Security 24906P109 Meeting Type Annual
Ticker Symbol XRAY Meeting Date 25-May-2022
Record Date 28-Mar-2022    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1A.   Election of Director: Eric K. Brandt   Management   For   For  
1B.   Election of Director: Donald M. Casey Jr.   Management   For   For  
1C.   Election of Director: Willie A. Deese   Management   For   For  
1D.   Election of Director: John P. Groetelaars   Management   For   For  
1E.   Election of Director: Betsy D. Holden   Management   For   For  
1F.   Election of Director: Clyde R. Hosein   Management   For   For  
1G.   Election of Director: Harry M. Kraemer Jr.   Management   For   For  
1H.   Election of Director: Gregory T. Lucier   Management   For   For  
1I.   Election of Director: Leslie F. Varon   Management   For   For  
1J.   Election of Director: Janet S. Vergis   Management   For   For  
1K.   Election of Director: Dorothea Wenzel   Management   For   For  
2.   Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accountants for 2022.   Management   For   For  
3.   Approval, by non-binding vote, of the Company's executive compensation.   Management   For   For  
4.   Approval of the Amendment to the Fifth Amended and Restated By- Laws to Designate the Exclusive Forum for the Adjudication of Certain Legal Matters.   Management   For   For  

 

 

 

 

DEXCOM, INC.

 

Security 252131107 Meeting Type Annual
Ticker Symbol DXCM Meeting Date 19-May-2022
Record Date 31-Mar-2022    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1.1   Election of Class II Director to hold office until our 2023 Annual Meeting: Steven R. Altman   Management   For   For  
1.2   Election of Class II Director to hold office until our 2023 Annual Meeting: Barbara E. Kahn   Management   For   For  
1.3   Election of Class II Director to hold office until our 2023 Annual Meeting: Kyle Malady   Management   For   For  
1.4   Election of Class II Director to hold office until our 2023 Annual Meeting: Jay S. Skyler, MD, MACP   Management   For   For  
2.   To ratify the selection by the Audit Committee of our Board of Directors of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2022.   Management   For   For  
3.   To hold a non-binding vote on an advisory resolution to approve executive compensation.   Management   For   For  
4.   To approve the amendment and restatement of our Restated Certificate of Incorporation to (i) effect a 4:1 forward split of our Common Stock (the "Forward Stock Split") and (ii) increase the number of shares of authorized Common Stock to effectuate the Forward Stock Split.   Management   For   For  

 

DIVERSIFIED HEALTHCARE TRUST

 

Security 25525P107 Meeting Type Annual
Ticker Symbol DHC Meeting Date 02-Jun-2022
Record Date 22-Mar-2022    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1A.   Election of Independent Trustee: Lisa Harris Jones   Management   For   For  
1B.   Election of Independent Trustee: John L. Harrington   Management   For   For  
1C.   Election of Managing Trustee: Jennifer F. Francis   Management   For   For  
1D.   Election of Managing Trustee: Adam D. Portnoy   Management   For   For  
2.   Advisory vote to approve executive compensation.   Management   For   For  
3.   Approval of the Amended and Restated 2012 Equity Compensation Plan.   Management   For   For  
4.   Ratification of the appointment of Deloitte & Touche LLP as independent auditors to serve for the 2022 fiscal year.   Management   For   For  

 

 

 

 

EDWARDS LIFESCIENCES CORPORATION

 

Security 28176E108 Meeting Type Annual
Ticker Symbol EW Meeting Date 03-May-2022
Record Date 09-Mar-2022    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1.1   Election of Director: Kieran T. Gallahue   Management   For   For  
1.2   Election of Director: Leslie S. Heisz   Management   For   For  
1.3   Election of Director: Paul A. LaViolette   Management   For   For  
1.4   Election of Director: Steven R. Loranger   Management   For   For  
1.5   Election of Director: Martha H. Marsh   Management   For   For  
1.6   Election of Director: Michael A. Mussallem   Management   For   For  
1.7   Election of Director: Ramona Sequeira   Management   For   For  
1.8   Election of Director: Nicholas J. Valeriani   Management   For   For  
2.   Advisory Vote to Approve Named Executive Officer Compensation   Management   For   For  
3.   Ratification of Appointment of Independent Registered Public Accounting Firm   Management   For   For  
4.   Stockholder Proposal for an Advisory Vote to Reduce the Share Ownership Threshold to Call a Special Meeting   Shareholder   Against   For  

 

 

 

 

ELI LILLY AND COMPANY

 

Security 532457108 Meeting Type Annual
Ticker Symbol LLY Meeting Date 02-May-2022
Record Date 22-Feb-2022    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1A.   Election of Director to serve a three-year term: Ralph Alvarez   Management   For   For  
1B.   Election of Director to serve a three-year term: Kimberly H. Johnson   Management   For   For  
1C.   Election of Director to serve a three-year term: Juan R. Luciano   Management   For   For  
2.   Approval, on an advisory basis, of the compensation paid to the company's named executive officers.   Management   For   For  
3.   Ratification of the appointment of Ernst & Young LLP as the independent auditor for 2022.   Management   For   For  
4.   Approval of amendments to the company's Articles of Incorporation to eliminate the classified board structure.   Management   For   For  
5.   Approval of amendments to the company's Articles of Incorporation to eliminate supermajority voting provisions.   Management   For   For  
6.   Approval of amendments to the company's Articles of Incorporation to give shareholders the ability to amend the company's bylaws.   Management   For   For  
7.   Shareholder proposal to amend the bylaws to require an independent board chair.   Shareholder   For   Against  
8.   Shareholder proposal to publish an annual report disclosing lobbying activities.   Shareholder   Against   For  
9.   Shareholder proposal to disclose lobbying activities and alignment with public policy positions and statements.   Shareholder   Against   For  
10.   Shareholder proposal to report oversight of risks related to anticompetitive pricing strategies.   Shareholder   Against   For  

 

ENDEAVOR BIOMEDICINES, INC.

 

Security N/A Meeting Type Written Consent
Ticker Symbol N/A Meeting Date 03-Mar-2022
Record Date N/A    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1.   Amendment to Amended and Restated Certificate of Incorporation.   Management   For   For  
2.   Amendment to Series B Preferred Stock Purchase Agreement.   Management   For   For  
3.   General Authority and Ratification.   Management   For   For  

 

 

 

 

GALERA THERAPEUTICS, INC.

 

Security 36338D108 Meeting Type Annual
Ticker Symbol GRTX Meeting Date 15-Jun-2022
Record Date 22-Apr-2022    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1.   DIRECTOR   Management          
    1. Emmett Cunningham       For   For  
    2. J. Mel Sorensen       For   For  
2.   To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2022.   Management   For   For  

 

GILEAD SCIENCES, INC.

 

Security 375558103 Meeting Type Annual
Ticker Symbol GILD Meeting Date 04-May-2022
Record Date 15-Mar-2022    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1A.   Election of Director: Jacqueline K. Barton, Ph.D.   Management   For   For  
1B.   Election of Director: Jeffrey A. Bluestone, Ph.D.   Management   For   For  
1C.   Election of Director: Sandra J. Horning, M.D.   Management   For   For  
1D.   Election of Director: Kelly A. Kramer   Management   For   For  
1E.   Election of Director: Kevin E. Lofton   Management   For   For  
1F.   Election of Director: Harish Manwani   Management   For   For  
1G.   Election of Director: Daniel P. O'Day   Management   For   For  
1H.   Election of Director: Javier J. Rodriguez   Management   For   For  
1I.   Election of Director: Anthony Welters   Management   For   For  
2.   To ratify the selection of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2022.   Management   For   For  
3.   To approve, on an advisory basis, the compensation of our Named Executive Officers as presented in the Proxy Statement.   Management   For   For  
4.   To approve the Gilead Sciences, Inc. 2022 Equity Incentive Plan.   Management   For   For  
5.   To vote on a stockholder proposal, if properly presented at the meeting, requesting that the Board adopt a policy that the Chairperson of the Board of Directors be an independent director.   Shareholder   Against   For  
6.   To vote on a stockholder proposal, if properly presented at the meeting, requesting that the Board include one member from Gilead's non-management employees.   Shareholder   Against   For  
7.   To vote on a stockholder proposal, if properly presented at the meeting, requesting a 10% threshold to call a special stockholder meeting.   Shareholder   Against   For  
8.   To vote on a stockholder proposal, if properly presented at the meeting, requesting that the Board publish a third- party review of Gilead's lobbying activities.   Shareholder   Against   For  
9.   To vote on a stockholder proposal, if properly presented at the meeting, requesting a Board report on oversight of risks related to anticompetitive practices.   Shareholder   Against   For  

 

 

 

 

 

GLOBAL MEDICAL REIT, INC.

 

Security 37954A204 Meeting Type Annual
Ticker Symbol GMRE Meeting Date 11-May-2022
Record Date 15-Mar-2022    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1.1   Election of Director to serve until next annual meeting: Jeffrey M. Busch   Management   For   For  
1.2   Election of Director to serve until next annual meeting: Matthew Cypher   Management   For   For  
1.3   Election of Director to serve until next annual meeting: Ronald Marston   Management   For   For  
1.4   Election of Director to serve until next annual meeting: Roscoe Moore, Jr.   Management   For   For  
1.5   Election of Director to serve until next annual meeting: Henry E. Cole   Management   For   For  
1.6   Election of Director to serve until next annual meeting: Zhang Huiqi   Management   For   For  
1.7   Election of Director to serve until next annual meeting: Paula R. Crowley   Management   For   For  
1.8   Election of Director to serve until next annual meeting: Lori Wittman   Management   For   For  
2.   Advisory vote to approve the compensation of the Company's named executive officers as described in the accompanying Proxy Statement.   Management   For   For  
3.   To ratify the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the year ending December 31, 2022.   Management   For   For  

 

 

 

 

GUARDANT HEALTH, INC.

 

Security 40131M109 Meeting Type Annual
Ticker Symbol GH Meeting Date 15-Jun-2022
Record Date 18-Apr-2022    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1A.   Election of Class I Director: Vijaya Gadde   Management   For   For  
1B.   Election of Class I Director: Myrtle Potter   Management   For   For  
2.   Ratification of the appointment of Ernst & Young LLP as Guardant Health, Inc.'s independent registered public accounting firm for the year ending December 31, 2022.   Management   For   For  
3.   Non-binding advisory vote to approve Guardant Health, Inc.'s named executive officer compensation.   Management   For   For  

 

 

 

 

HCA HEALTHCARE, INC.

 

Security 40412C101 Meeting Type Annual
Ticker Symbol HCA Meeting Date 21-Apr-2022
Record Date 25-Feb-2022    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1A.   Election of Director: Thomas F. Frist III   Management   For   For  
1B.   Election of Director: Samuel N. Hazen   Management   For   For  
1C.   Election of Director: Meg G. Crofton   Management   For   For  
1D.   Election of Director: Robert J. Dennis   Management   For   For  
1E.   Election of Director: Nancy-Ann DeParle   Management   For   For  
1F.   Election of Director: William R. Frist   Management   For   For  
1G.   Election of Director: Charles O. Holliday, Jr.   Management   For   For  
1H.   Election of Director: Hugh F. Johnston   Management   For   For  
1I.   Election of Director: Michael W. Michelson   Management   For   For  
1J.   Election of Director: Wayne J. Riley, M.D.   Management   For   For  
1K.   Election of Director: Andrea B. Smith   Management   For   For  
2.   To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2022.   Management   For   For  
3.   Advisory vote to approve named executive officer compensation.   Management   For   For  
4.   Stockholder proposal, if properly presented at the meeting, regarding political spending disclosure.   Shareholder   Against   For  
5.   Stockholder proposal, if properly presented at the meeting, regarding lobbying disclosure.   Shareholder   Against   For  

 

 

 

 

HEALTHCARE REALTY TRUST INCORPORATED

 

Security 421946104 Meeting Type Annual
Ticker Symbol HR Meeting Date 10-May-2022
Record Date 16-Mar-2022    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1.   DIRECTOR   Management          
    1. Todd J. Meredith       For   For  
    2. John V. Abbott       For   For  
    3. Nancy H. Agee       For   For  
    4. Edward H. Braman       For   For  
    5. Ajay Gupta       For   For  
    6. James J. Kilroy       For   For  
    7. Peter F. Lyle, Sr.       For   For  
    8. John Knox Singleton       For   For  
    9. Christann M. Vasquez       For   For  
2.   To ratify the appointment of BDO USA, LLP as the independent registered public accounting firm for the Company and its subsidiaries for the Company's 2022 fiscal year.   Management   For   For  
3.   To approve, on a non-binding advisory basis, the following resolution: RESOLVED, that the shareholders of Healthcare Realty Trust Incorporated approve, on a non-binding advisory basis, the compensation of the Named Executive Officers as disclosed pursuant to Item 402 of Regulation S-K in the Company's proxy statement for the 2022 Annual Meeting of Shareholders.   Management   For   For  

 

 

 

 

HEALTHCARE REALTY TRUST INCORPORATED

 

Security 421946104 Meeting Type Special
Ticker Symbol HR Meeting Date 15-Jul-2022
Record Date 10-Jun-2022    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1.   To approve the merger of HR Acquisition 2, LLC, a Maryland limited liability company and a direct, wholly- owned subsidiary of Healthcare Trust of America, Inc., a Maryland corporation (the "Company"), with and into Healthcare Realty Trust Incorporated, a Maryland Corporation ("HR"),with HR continuing as the surviving entity and a direct, wholly-owned subsidiary of the Company, pursuant to which each outstanding share of HR common stock will be exchanged for one newly- issued share of the Company's class A common stock.   Management   For   For  
2.   To approve the adjournment of the special meeting, if necessary or appropriate, including to solicit additional proxies in favor of Proposal 1 if there are insufficient votes at the time of such adjournment to approve Proposal 1.   Management   For   For  

 

HEALTHEQUITY, INC.

 

Security 42226A107 Meeting Type Annual
Ticker Symbol HQY Meeting Date 23-Jun-2022
Record Date 29-Apr-2022    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1a.   Robert Selander   Management   For   For  
1b.   Jon Kessler   Management   For   For  
1c.   Stephen Neeleman, M.D.   Management   For   For  
1d.   Frank Corvino   Management   For   For  
1e.   Adrian Dillon   Management   For   For  
1f.   Evelyn Dilsaver   Management   For   For  
1g.   Debra McCowan   Management   For   For  
1h.   Rajesh Natarajan   Management   For   For  
1i.   Stuart Parker   Management   For   For  
1j.   Ian Sacks   Management   For   For  
1k.   Gayle Wellborn   Management   For   For  
2.   To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for our fiscal year ending January 31, 2023.   Management   For   For  
3.   To approve, on a non-binding, advisory basis, the fiscal 2022 compensation paid to our named executive officers.   Management   For   For  

 

 

 

 

 

 

HEALTHPEAK PROPERTIES, INC.

 

Security 42250P103 Meeting Type Annual
Ticker Symbol PEAK Meeting Date 28-Apr-2022
Record Date 01-Mar-2022

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1A.   Election of Director: Brian G. Cartwright   Management   For   For  
1B.   Election of Director: Christine N. Garvey   Management   For   For  
1C.   Election of Director: R. Kent Griffin, Jr.   Management   For   For  
1D.   Election of Director: David B. Henry   Management   For   For  
1E.   Election of Director: Thomas M. Herzog   Management   For   For  
1F.   Election of Director: Lydia H. Kennard   Management   For   For  
1G.   Election of Director: Sara G. Lewis   Management   For   For  
1H.   Election of Director: Katherine M. Sandstrom   Management   For   For  
2.   Approval of 2021 executive compensation on an advisory basis.   Management   For   For  
3.   Ratification of the appointment of Deloitte & Touche LLP as Healthpeak Properties, Inc.'s independent registered public accounting firm for the year ending December 31, 2022.   Management   For   For  

 

HOLOGIC, INC.

 

Security 436440101 Meeting Type Annual
Ticker Symbol HOLX Meeting Date 10-Mar-2022
Record Date 11-Jan-2022    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1A.   Election of Director: Stephen P. MacMillan   Management   For   For  
1B.   Election of Director: Sally W. Crawford   Management   For   For  
1C.   Election of Director: Charles J. Dockendorff   Management   For   For  
1D.   Election of Director: Scott T. Garrett   Management   For   For  
1E.   Election of Director: Ludwig N. Hantson   Management   For   For  
1F.   Election of Director: Namal Nawana   Management   For   For  
1G.   Election of Director: Christiana Stamoulis   Management   For   For  
1H.   Election of Director: Amy M. Wendell   Management   For   For  
2.   A non-binding advisory resolution to approve executive compensation.   Management   For   For  
3.   Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for fiscal 2022.   Management   For   For  

 

 

 

 

HORIZON THERAPEUTICS PLC

 

Security G46188101 Meeting Type Annual
Ticker Symbol HZNP Meeting Date 28-Apr-2022
Record Date 24-Feb-2022    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1A.   Election of Class II Director: Michael Grey   Management   For   For  
1B.   Election of Class II Director: Jeff Himawan, Ph.D.   Management   For   For  
1C.   Election of Class II Director: Susan Mahony, Ph.D.   Management   For   For  
2.   Approval of the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2022 and authorization of the Audit Committee to determine the auditors' remuneration.   Management   For   For  
3.   Approval, on an advisory basis, of the compensation of our named executive officers, as disclosed in the Proxy Statement.   Management   For   For  
4.   Authorization for us and/or any of our subsidiaries to make market purchases or overseas market purchases of our ordinary shares.   Management   For   For  
5.   Approval of the Amended and Restated 2020 Equity Incentive Plan.   Management   For   For  

 

 

 

 

HUMANA, INC.

 

Security 444859102 Meeting Type Annual
Ticker Symbol HUM Meeting Date 21-Apr-2022
Record Date 28-Feb-2022    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1A)   Election of Director: Raquel C. Bono, M.D.   Management   For   For  
1B)   Election of Director: Bruce D. Broussard   Management   For   For  
1C)   Election of Director: Frank A. D'Amelio   Management   For   For  
1D)   Election of Director: David T. Feinberg, M.D.   Management   For   For  
1E)   Election of Director: Wayne A. I. Frederick, M.D.   Management   For   For  
1F)   Election of Director: John W. Garratt   Management   For   For  
1G)   Election of Director: Kurt J. Hilzinger   Management   For   For  
1H)   Election of Director: David A. Jones, Jr.   Management   For   For  
1I)   Election of Director: Karen W. Katz   Management   For   For  
1J)   Election of Director: Marcy S. Klevorn   Management   For   For  
1K)   Election of Director: William J. McDonald   Management   For   For  
1L)   Election of Director: Jorge S. Mesquita   Management   For   For  
1M)   Election of Director: James J. O'Brien   Management   For   For  
2)   The ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm.   Management   For   For  
3)   Non-binding advisory vote for the approval of the compensation of the named executive officers as disclosed in the 2022 proxy statement.   Management   For   For  

 

 

 

 

IDEXX LABORATORIES, INC.

 

Security 45168D104 Meeting Type Annual
Ticker Symbol IDXX Meeting Date 11-May-2022
Record Date 14-Mar-2022    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1A.   Election of Director (Proposal One): Jonathan W. Ayers   Management   For   For  
1B.   Election of Director (Proposal One): Stuart M. Essig, PhD   Management   For   For  
1C.   Election of Director (Proposal One): Jonathan J. Mazelsky   Management   For   For  
1D.   Election of Director (Proposal One): M. Anne Szostak   Management   For   For  
2.   Ratification of Appointment of Independent Registered Public Accounting Firm. To ratify the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the current fiscal year (Proposal Two).   Management   For   For  
3.   Advisory Vote on Executive Compensation. To approve a nonbinding advisory resolution on the Company's executive compensation (Proposal Three).   Management   For   For  

 

ILLUMINA, INC.

 

Security 452327109 Meeting Type Annual
Ticker Symbol ILMN Meeting Date 26-May-2022
Record Date 31-Mar-2022    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1A.   Election of Director: Frances Arnold, Ph.D.   Management   For   For  
1B.   Election of Director: Francis A. deSouza   Management   For   For  
1C.   Election of Director: Caroline D. Dorsa   Management   For   For  
1D.   Election of Director: Robert S. Epstein, M.D.   Management   For   For  
1E.   Election of Director: Scott Gottlieb, M.D.   Management   For   For  
1F.   Election of Director: Gary S. Guthart, Ph.D.   Management   For   For  
1G.   Election of Director: Philip W. Schiller   Management   For   For  
1H.   Election of Director: Susan E. Siegel   Management   For   For  
1I.   Election of Director: John W. Thompson   Management   For   For  
2.   To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending January 1, 2023.   Management   For   For  
3.   To approve, on an advisory basis, the compensation of the named executive officers as disclosed in the Proxy Statement.   Management   For   For  
4.   To approve, on an advisory basis, a stockholder proposal regarding the right of stockholders to call special meetings.   Shareholder   Against   For  
5.   To approve an amendment to our Amended and Restated Certificate of Incorporation to permit stockholders to call special meetings.   Management   For   For  

 

 

 

 

INTUITIVE SURGICAL, INC.

 

Security 46120E602 Meeting Type Special
Ticker Symbol ISRG Meeting Date 20-Sep-2021
Record Date 18-Aug-2021    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1.   TO APPROVE THE COMPANY'S AMENDED AND RESTATED CERTIFICATE OF INCORPORATION TO INCREASE THE NUMBER OF AUTHORIZED SHARES OF COMMON STOCK FOR THE PURPOSE OF EFFECTING A THREE-FOR-ONE STOCK SPLIT.   Management   For   For  

 

INTUITIVE SURGICAL, INC.

 

Security 46120E602 Meeting Type Annual
Ticker Symbol ISRG Meeting Date 28-Apr-2022
Record Date 01-Mar-2022    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1A.   Election of Director: Craig H. Barratt, Ph.D.   Management   For   For  
1B.   Election of Director: Joseph C. Beery   Management   For   For  
1C.   Election of Director: Gary S. Guthart, Ph.D.   Management   For   For  
1D.   Election of Director: Amal M. Johnson   Management   For   For  
1E.   Election of Director: Don R. Kania, Ph.D.   Management   For   For  
1F.   Election of Director: Amy L. Ladd, M.D.   Management   For   For  
1G.   Election of Director: Keith R. Leonard, Jr.   Management   For   For  
1H.   Election of Director: Alan J. Levy, Ph.D.   Management   For   For  
1I.   Election of Director: Jami Dover Nachtsheim   Management   For   For  
1J.   Election of Director: Monica P. Reed, M.D.   Management   For   For  
1K.   Election of Director: Mark J. Rubash   Management   For   For  
2.   To approve, by advisory vote, the compensation of the Company's Named Executive Officers.   Management   For   For  
3.   The ratification of appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2022.   Management   For   For  
4.   To approve the Company's Amended and Restated 2010 Incentive Award Plan.   Management   For   For  

 

 

 

 

 

IQVIA HOLDINGS, INC.

 

Security 46266C105 Meeting Type Annual
Ticker Symbol IQV Meeting Date 12-Apr-2022
Record Date 15-Feb-2022    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1.   DIRECTOR   Management          
    1. John P. Connaughton       For   For  
    2. John G. Danhakl       For   For  
    3. James A. Fasano       For   For  
    4. Leslie Wims Morris       For   For  
2.   Amendment to Certificate of Incorporation to declassify the Board of Directors over time and provide for the annual election of all directors.   Management   For   For  
3.   Advisory (non-binding) vote to approve executive compensation (say-on-pay).   Management   For   For  
4.   If properly presented, a shareholder proposal regarding majority voting in uncontested director elections.   Management   Against   For  
5.   The ratification of the appointment of PricewaterhouseCoopers LLP as IQVIA Holdings Inc.'s independent registered public accounting firm for the year ending December 31, 2022.   Management   For   For  

 

 

 

 

JOHNSON & JOHNSON

 

Security 478160104 Meeting Type Annual
Ticker Symbol JNJ Meeting Date 28-Apr-2022
Record Date 01-Mar-2022    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1A.   Election of Director: Darius Adamczyk   Management   For   For  
1B.   Election of Director: Mary C. Beckerle   Management   For   For  
1C.   Election of Director: D. Scott Davis   Management   For   For  
1D.   Election of Director: Ian E. L. Davis   Management   For   For  
1E.   Election of Director: Jennifer A. Doudna   Management   For   For  
1F.   Election of Director: Joaquin Duato   Management   For   For  
1G.   Election of Director: Alex Gorsky   Management   For   For  
1H.   Election of Director: Marillyn A. Hewson   Management   For   For  
1I.   Election of Director: Hubert Joly   Management   For   For  
1J.   Election of Director: Mark B. McClellan   Management   For   For  
1K.   Election of Director: Anne M. Mulcahy   Management   For   For  
1L.   Election of Director: A. Eugene Washington   Management   For   For  
1M.   Election of Director: Mark A. Weinberger   Management   For   For  
1N.   Election of Director: Nadja Y. West   Management   For   For  
2.   Advisory Vote to Approve Named Executive Officer Compensation.   Management   For   For  
3.   Approval of the Company's 2022 Long-Term Incentive Plan.   Management   For   For  
4.   Ratification of Appointment of PricewaterhouseCoopers LLP as the Independent Registered Public Accounting Firm for 2022.   Management   For   For  
5.   Proposal Withdrawn (Federal Securities Laws Mandatory Arbitration Bylaw).   Shareholder   Against    
6.   Civil Rights, Equity, Diversity & Inclusion Audit Proposal.   Shareholder   Against   For  
7.   Third Party Racial Justice Audit.   Shareholder   Against   For  
8.   Report on Government Financial Support and Access to COVID-19 Vaccines and Therapeutics.   Shareholder   Against   For  
9.   Report on Public Health Costs of Protecting Vaccine Technology.   Shareholder   Against   For  
10.   Discontinue Global Sales of Baby Powder Containing Talc.   Shareholder   Against   For  
11.   Request for Charitable Donations Disclosure.   Shareholder   Against   For  
12.   Third Party Review and Report on Lobbying Activities Alignment with Position on Universal Health Coverage.   Shareholder   Against   For  
13.   Adopt Policy to Include Legal and Compliance Costs in Incentive Compensation Metrics.   Shareholder   Against   For  
14.   CEO Compensation to Weigh Workforce Pay and Ownership.   Shareholder   Against   For  
                     

 

 

 

 

LABORATORY CORP. OF AMERICA HOLDINGS

 

Security 50540R409 Meeting Type Annual
Ticker Symbol LH Meeting Date 11-May-2022
Record Date 16-Mar-2022    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1A.   Election of Director: Kerrii B. Anderson   Management   For   For  
1B.   Election of Director: Jean-Luc Bélingard   Management   For   For  
1C.   Election of Director: Jeffrey A. Davis   Management   For   For  
1D.   Election of Director: D. Gary Gilliland, M.D., Ph.D.   Management   For   For  
1E.   Election of Director: Garheng Kong, M.D., Ph.D.   Management   For   For  
1F.   Election of Director: Peter M. Neupert   Management   For   For  
1G.   Election of Director: Richelle P. Parham   Management   For   For  
1H.   Election of Director: Adam H. Schechter   Management   For   For  
1I.   Election of Director: Kathryn E. Wengel   Management   For   For  
1J.   Election of Director: R. Sanders Williams, M.D.   Management   For   For  
2.   To approve, by non-binding vote, executive compensation.   Management   For   For  
3.   Ratification of the appointment of Deloitte and Touche LLP as Laboratory Corporation of America Holdings' independent registered public accounting firm for the year ending December 31, 2022.   Management   For   For  
4.   Shareholder proposal seeking an amendment to our governing documents relating to procedural requirements in connection with shareholders' rights to call a special meeting.   Shareholder   Against   For  

 

 

 

 

LTC PROPERTIES, INC.

 

Security 502175102 Meeting Type Annual
Ticker Symbol LTC Meeting Date 25-May-2022
Record Date 11-Apr-2022    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1A.   Election of Director to hold office until the 2023 Annual Meeting: Cornelia Cheng   Management   For   For  
1B.   Election of Director to hold office until the 2023 Annual Meeting: Boyd W. Hendrickson   Management   For   For  
1C.   Election of Director to hold office until the 2023 Annual Meeting: James J. Pieczynski   Management   For   For  
1D.   Election of Director to hold office until the 2023 Annual Meeting: Devra G. Shapiro   Management   For   For  
1E.   Election of Director to hold office until the 2023 Annual Meeting: Wendy L. Simpson   Management   For   For  
1F.   Election of Director to hold office until the 2023 Annual Meeting: Timothy J. Triche   Management   For   For  
2.   Ratification of independent registered public accounting firm.   Management   For   For  
3.   Advisory vote to approve named executive officer compensation.   Management   For   For  

 

MCKESSON CORPORATION

 

Security 58155Q103 Meeting Type Annual
Ticker Symbol MCK Meeting Date 23-Jul-2021
Record Date 28-May-2021    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1A.   Election of Director for a one-year term: Dominic J. Caruso   Management   For   For  
1B.   Election of Director for a one-year term: Donald R. Knauss   Management   For   For  
1C.   Election of Director for a one-year term: Bradley E. Lerman   Management   For   For  
1D.   Election of Director for a one-year term: Linda P. Mantia   Management   For   For  
1E.   Election of Director for a one-year term: Maria Martinez   Management   For   For  
1F.   Election of Director for a one-year term: Edward A. Mueller   Management   For   For  
1G.   Election of Director for a one-year term: Susan R. Salka   Management   For   For  
1H.   Election of Director for a one-year term: Brian S. Tyler   Management   For   For  
1I.   Election of Director for a one-year term: Kenneth E. Washington   Management   For   For  
2.   Ratification of the appointment of Deloitte & Touche LLP as the company's independent registered public accounting firm for the fiscal year ending March 31, 2022.   Management   For   For  
3.   Advisory vote on executive compensation.   Management   For   For  
4.   Shareholder proposal on action by written consent of shareholders.   Shareholder   Against   For  

 

 

 

 

 

MEDICAL PROPERTIES TRUST, INC.

 

Security 58463J304 Meeting Type Annual
Ticker Symbol MPW Meeting Date 26-May-2022
Record Date 29-Mar-2022    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1.1   Election of Director: Edward K. Aldag, Jr.   Management   For   For  
1.2   Election of Director: G. Steven Dawson   Management   For   For  
1.3   Election of Director: R. Steven Hamner   Management   For   For  
1.4   Election of Director: Caterina A. Mozingo   Management   For   For  
1.5   Election of Director: Emily W. Murphy   Management   For   For  
1.6   Election of Director: Elizabeth N. Pitman   Management   For   For  
1.7   Election of Director: D. Paul Sparks, Jr.   Management   For   For  
1.8   Election of Director: Michael G. Stewart   Management   For   For  
1.9   Election of Director: C. Reynolds Thompson, III   Management   For   For  
2.   To ratify the appointment of PricewaterhouseCoopers LLP as independent registered public accounting firm for the fiscal year ending December 31, 2022.   Management   For   For  
3.   To approve the compensation of the Company's executive officers, on a non-binding basis.   Management   For   For  
4.   To approve the Medical Properties Trust, Inc. Amended and Restated 2019 Equity Investment Plan.   Management   For   For  

 

 

 

 

MEDTRONIC PLC

 

Security G5960L103 Meeting Type Annual
Ticker Symbol MDT Meeting Date 09-Dec-2021
Record Date 14-Oct-2021    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1A.   Election of Director until the 2022 Annual General Meeting: Richard H. Anderson   Management   For   For  
1B.   Election of Director until the 2022 Annual General Meeting: Craig Arnold   Management   For   For  
1C.   Election of Director until the 2022 Annual General Meeting: Scott C. Donnelly   Management   For   For  
1D.   Election of Director until the 2022 Annual General Meeting: Andrea J. Goldsmith, Ph.D.   Management   For   For  
1E.   Election of Director until the 2022 Annual General Meeting: Randall J. Hogan, III   Management   For   For  
1F.   Election of Director until the 2022 Annual General Meeting: Kevin E. Lofton   Management   For   For  
1G.   Election of Director until the 2022 Annual General Meeting: Geoffrey S. Martha   Management   For   For  
1H.   Election of Director until the 2022 Annual General Meeting: Elizabeth G. Nabel, M.D.   Management   For   For  
1I.   Election of Director until the 2022 Annual General Meeting: Denise M. O'Leary   Management   For   For  
1J.   Election of Director until the 2022 Annual General Meeting: Kendall J. Powell   Management   For   For  
2.   Ratifying, in a non-binding vote, the appointment of PricewaterhouseCoopers LLP as the Company's independent auditor for fiscal year 2022 and authorizing, in a binding vote, the Board of Directors, acting through the Audit Committee, to set the auditor's remuneration.   Management   For   For  
3.   Approving, on an advisory basis, the Company's executive compensation.   Management   For   For  
4.   Approving, on an advisory basis, the frequency of Say- on-Pay votes.   Management   1 Year   For  
5.   Approving the new 2021 Medtronic plc Long Term Incentive Plan.   Management   For   For  
6.   Renewing the Board of Directors' authority to issue shares under Irish law.   Management   For   For  
7.   Renewing the Board of Directors' authority to opt out of pre- emption rights under Irish law.   Management   For   For  
8.   Authorizing the Company and any subsidiary of the Company to make overseas market purchases of Medtronic ordinary shares.   Management   For   For  

 

 

 

 

MERCK & CO., INC.

 

Security 58933Y105 Meeting Type Annual
Ticker Symbol MRK Meeting Date 24-May-2022
Record Date 25-Mar-2022    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1A.   Election of Director: Douglas M. Baker, Jr.   Management   For   For  
1B.   Election of Director: Mary Ellen Coe   Management   For   For  
1C.   Election of Director: Pamela J. Craig   Management   For   For  
1D.   Election of Director: Robert M. Davis   Management   For   For  
1E.   Election of Director: Kenneth C. Frazier   Management   For   For  
1F.   Election of Director: Thomas H. Glocer   Management   For   For  
1G.   Election of Director: Risa J. Lavizzo-Mourey, M.D.   Management   For   For  
1H.   Election of Director: Stephen L. Mayo, Ph.D.   Management   For   For  
1I.   Election of Director: Paul B. Rothman, M.D.   Management   For   For  
1J.   Election of Director: Patricia F. Russo   Management   For   For  
1K.   Election of Director: Christine E. Seidman, M.D.   Management   For   For  
1L.   Election of Director: Inge G. Thulin   Management   For   For  
1M.   Election of Director: Kathy J. Warden   Management   For   For  
1N.   Election of Director: Peter C. Wendell   Management   For   For  
2.   Non-binding advisory vote to approve the compensation of our named executive officers.   Management   For   For  
3.   Ratification of the appointment of the Company's independent registered public accounting firm for 2022.   Management   For   For  
4.   Shareholder proposal regarding an independent board chairman.   Shareholder   For   Against  
5.   Shareholder proposal regarding access to COVID-19 products.   Shareholder   Against   For  
6.   Shareholder proposal regarding lobbying expenditure disclosure.   Shareholder   Against   For  

 

METTLER-TOLEDO INTERNATIONAL, INC.

 

Security 592688105 Meeting Type Annual
Ticker Symbol MTD Meeting Date 05-May-2022
Record Date 07-Mar-2022    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1.1   Election of Director: Robert F. Spoerry   Management   For   For  
1.2   Election of Director: Wah-Hui Chu   Management   For   For  
1.3   Election of Director: Domitille Doat-Le Bigot   Management   For   For  
1.4   Election of Director: Olivier A. Filliol   Management   For   For  
1.5   Election of Director: Elisha W. Finney   Management   For   For  
1.6   Election of Director: Richard Francis   Management   For   For  
1.7   Election of Director: Michael A. Kelly   Management   For   For  
1.8   Election of Director: Thomas P. Salice   Management   For   For  
2.   RATIFICATION OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM.   Management   For   For  
3.   ADVISORY VOTE TO APPROVE EXECUTIVE COMPENSATION.   Management   For   For  

 

 

 

 

MODERNA, INC.

 

Security 60770K107 Meeting Type Annual
Ticker Symbol MRNA Meeting Date 28-Apr-2022
Record Date 01-Mar-2022    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1.   DIRECTOR   Management          
    1 Noubar Afeyan, Ph.D.       For   For  
    2 Stéphane Bancel       For   For  
    3 François Nader, M.D.       For   For  
2.   To approve, on a non-binding, advisory basis, the compensation of our named executive officers.   Management   For   For  
3.   To ratify the appointment of Ernst & Young LLP as our registered independent public accounting firm for the year ending December 31, 2022.   Management   For   For  
4.   To vote on a shareholder proposal relating to the feasibility of transferring intellectual property.   Shareholder   For   Against  

 

MOLINA HEALTHCARE, INC.

 

Security 60855R100 Meeting Type Annual
Ticker Symbol MOH Meeting Date 04-May-2022
Record Date 07-Mar-2022    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1A.   Election of Director to hold office until the 2023 Annual Meeting: Barbara L. Brasier   Management   For   For  
1B.   Election of Director to hold office until the 2023 Annual Meeting: Daniel Cooperman   Management   For   For  
1C.   Election of Director to hold office until the 2023 Annual Meeting: Stephen H. Lockhart   Management   For   For  
1D.   Election of Director to hold office until the 2023 Annual Meeting: Steven J. Orlando   Management   For   For  
1E.   Election of Director to hold office until the 2023 Annual Meeting: Ronna E. Romney   Management   For   For  
1F.   Election of Director to hold office until the 2023 Annual Meeting: Richard M. Schapiro   Management   For   For  
1G.   Election of Director to hold office until the 2023 Annual Meeting: Dale B. Wolf   Management   For   For  
1H.   Election of Director to hold office until the 2023 Annual Meeting: Richard C. Zoretic   Management   For   For  
1I.   Election of Director to hold office until the 2023 Annual Meeting: Joseph M. Zubretsky   Management   For   For  
2.   To consider and approve, on a non-binding, advisory basis, the compensation of our named executive officers.   Management   For   For  
3.   To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for 2022.   Management   For   For  

 

 

 

 

 

NATIONAL HEALTH INVESTORS, INC.

 

Security 63633D104 Meeting Type Annual
Ticker Symbol NHI Meeting Date 06-May-2022
Record Date 11-Mar-2022    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1A.   Election of Director: James R. Jobe   Management   For   For  
1B.   Election of Director: Robert G. Adams   Management   For   For  
2.   Approve the advisory resolution approving the compensation of the named executive officers as disclosed in the accompanying Proxy Statement.   Management   For   For  
3.   Ratify the audit committee's selection of BDO USA, LLP as independent registered public accounting firm for the year ending December 31, 2022.   Management   For   For  

 

NEW SENIOR INVESTMENT GROUP, INC.

 

Security 648691103 Meeting Type Special
Ticker Symbol SNR Meeting Date 14-Sep-2021
Record Date 06-Aug-2021    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1.   Adopt the Agreement and Plan of Merger, dated as of June 28, 2021 (as amended or otherwise modified from time to time, the "Merger Agreement"), by and among New Senior Investment Group Inc., a Delaware corporation ("New Senior"), Ventas, Inc., a Delaware corporation ("Ventas"), and Cadence Merger Sub LLC, a Delaware limited liability company and a subsidiary of Ventas, Inc. ("Merger Sub"), and thereby approve the merger of Merger Sub with and into New Senior, with New Senior continuing as the surviving corporation and a subsidiary of Ventas.   Management   For   For  
2.   Approve, by advisory (non-binding) vote, the compensation that may be paid or become payable to the named executive officers of New Senior in connection with transactions contemplated by the Merger Agreement.   Management   For   For  
3.   Approve the adjournment of the special meeting of the New Senior stockholders (the "Special Meeting") from time to time, if necessary or appropriate, (i) to solicit additional proxies in favor of the proposal to adopt the Merger Agreement if there are insufficient votes at the time of such adjournment to approve such proposal or (ii) if required to enable New Senior or Ventas to comply with the requirement in the Merger Agreement to provide notice to the other party 10 business days prior to the Special Meeting   Management   For   For  

 

 

 

 

OCULIS SA

 

Security N/A Meeting Type Written Consent
Ticker Symbol N/A Meeting Date 27-Apr-2022
Record Date N/A    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1.   Approval of the Financial Statements 2021.   Management   For   For  
2.   Appropriation of Balance Sheet Results 2021.   Management   For   For  
3.   Discharge of the Members of the Board and Management.   Management   For   For  
4.   Re-Election of the Board of Directors:              
4.1   Mr. Anthony (Tony) Rosenberg   Management   For   For  
4.2   Dr. Riad Sherif   Management   For   For  
4.3   Mr. Àrni Audunn Blöndal   Management   For   For  
4.4   Mr. Lionel Carnot   Management   For   For  
4.5   Mr. Bartosz Dzikowski   Management   For   For  
4.6   Dr. Xin (Sylvia) He   Management   For   For  
4.7   Dr. Robert Lorne Hopfner   Management   For   For  
4.8   Ms. Yi Fei (Vanessa) Huang   Management   For   For  
4.9   Dr. Henry Skinner   Management   For   For  
5.   Re-Election of the Auditors PricewaterhouseCoopers SA.   Management   For   For  

 

OCULIS SA

 

Security N/A Meeting Type Extraordinary General Meeting
Ticker Symbol N/A Meeting Date 30-Nov-2021
Record Date N/A    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1.   Ordinary share capital increase   Management   For   For  
2.   Conditional capital share increase   Management   For   For  

 

OMEGA HEALTHCARE INVESTORS, INC.

 

Security 681936100 Meeting Type Annual
Ticker Symbol OHI Meeting Date 03-Jun-2022
Record Date 06-Apr-2022    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1A.   Election of Director: Kapila K. Anand   Management   For   For  
1B.   Election of Director: Craig R. Callen   Management   For   For  
1C.   Election of Director: Dr. Lisa C. Egbuonu-Davis   Management   For   For  
1D.   Election of Director: Barbara B. Hill   Management   For   For  
1E.   Election of Director: Kevin J. Jacobs   Management   For   For  
1F.   Election of Director: C. Taylor Pickett   Management   For   For  
1G.   Election of Director: Stephen D. Plavin   Management   For   For  
1H.   Election of Director: Burke W. Whitman   Management   For   For  
2.   Ratification of Independent Auditors Ernst & Young LLP for fiscal year 2022.   Management   For   For  
3.   Approval, on an Advisory Basis, of Executive Compensation.   Management   For   For  

 

 

 

 

OWENS & MINOR, INC.

 

Security 690732102 Meeting Type Annual
Ticker Symbol OMI Meeting Date 29-Apr-2022
Record Date 04-Mar-2022    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1.1   Election of Director: Mark A. Beck   Management   For   For  
1.2   Election of Director: Gwendolyn M. Bingham   Management   For   For  
1.3   Election of Director: Kenneth Gardner-Smith   Management   For   For  
1.4   Election of Director: Robert J. Henkel   Management   For   For  
1.5   Election of Director: Stephen W. Klemash   Management   For   For  
1.6   Election of Director: Mark F. McGettrick   Management   For   For  
1.7   Election of Director: Edward A. Pesicka   Management   For   For  
2.   Ratification of the appointment of KPMG LLP as the Company's independent public accounting firm for the year ending December 31, 2022   Management   For   For  
3.   Advisory vote to approve the compensation of the Company's named executive officers   Management   For   For  
4.   Advisory vote on the frequency of a shareholder vote on the compensation of the Company's named executive officers   Management   1 Year   For  

 

PERKINELMER, INC.

 

Security 714046109 Meeting Type Annual
Ticker Symbol PKI Meeting Date 26-Apr-2022
Record Date 28-Feb-2022    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1A.   Election of Director for a term of one year: Peter Barrett, PhD   Management   For   For  
1B.   Election of Director for a term of one year: Samuel R. Chapin   Management   For   For  
1C.   Election of Director for a term of one year: Sylvie Grégoire, PharmD   Management   For   For  
1D.   Election of Director for a term of one year: Alexis P. Michas   Management   For   For  
1E.   Election of Director for a term of one year: Prahlad R. Singh, PhD   Management   For   For  
1F.   Election of Director for a term of one year: Michel Vounatsos   Management   For   For  
1G.   Election of Director for a term of one year: Frank Witney, PhD   Management   For   For  
1H.   Election of Director for a term of one year: Pascale Witz   Management   For   For  
2.   To ratify the selection of Deloitte & Touche LLP as PerkinElmer's independent registered public accounting firm for the current fiscal year.   Management   For   For  
3.   To approve, by non-binding advisory vote, our executive compensation.   Management   For   For  

 

 

 

 

 

 

 

PERRIGO COMPANY PLC

 

Security G97822103 Meeting Type Annual
Ticker Symbol PRGO Meeting Date 06-May-2022
Record Date 07-Mar-2022    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1A.   Election of Director to hold office until the 2023 Annual General Meeting of Shareholders: Bradley A. Alford   Management   For   For  
1B.   Election of Director to hold office until the 2023 Annual General Meeting of Shareholders: Orlando D. Ashford   Management   For   For  
1C.   Election of Director to hold office until the 2023 Annual General Meeting of Shareholders: Katherine C. Doyle   Management   For   For  
1D.   Election of Director to hold office until the 2023 Annual General Meeting of Shareholders: Adriana Karaboutis   Management   For   For  
1E.   Election of Director to hold office until the 2023 Annual General Meeting of Shareholders: Murray S. Kessler   Management   For   For  
1F.   Election of Director to hold office until the 2023 Annual General Meeting of Shareholders: Jeffrey B. Kindler   Management   For   For  
1G.   Election of Director to hold office until the 2023 Annual General Meeting of Shareholders: Erica L. Mann   Management   For   For  
1H.   Election of Director to hold office until the 2023 Annual General Meeting of Shareholders: Donal O'Connor   Management   For   For  
1I.   Election of Director to hold office until the 2023 Annual General Meeting of Shareholders: Geoffrey M. Parker   Management   For   For  
1J.   Election of Director to hold office until the 2023 Annual General Meeting of Shareholders: Theodore R. Samuels   Management   For   For  
2.   Ratify, in a non-binding advisory vote, the appointment of Ernst & Young LLP as the Company's independent auditor, and authorize, in a binding vote, the Board of Directors, acting through the Audit Committee, to fix the remuneration of the auditor   Management   For   For  
3.   Advisory vote on executive compensation   Management   For   For  
4.   Amend the Company's Long-Term Incentive Plan   Management   For   For  
5.   Renew the Board's authority to issue shares under Irish law   Management   For   For  
6.   Renew the Board's authority to opt-out of statutory pre- emption rights under Irish law   Management   For   For  

 

 

 

 

PFIZER, INC.

 

Security 717081103 Meeting Type Annual
Ticker Symbol PFE Meeting Date 28-Apr-2022
Record Date 02-Mar-2022    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1A.   Election of Director: Ronald E. Blaylock   Management   For   For  
1B.   Election of Director: Albert Bourla   Management   For   For  
1C.   Election of Director: Susan Desmond-Hellmann   Management   For   For  
1D.   Election of Director: Joseph J. Echevarria   Management   For   For  
1E.   Election of Director: Scott Gottlieb   Management   For   For  
1F.   Election of Director: Helen H. Hobbs   Management   For   For  
1G.   Election of Director: Susan Hockfield   Management   For   For  
1H.   Election of Director: Dan R. Littman   Management   For   For  
1I.   Election of Director: Shantanu Narayen   Management   For   For  
1J.   Election of Director: Suzanne Nora Johnson   Management   For   For  
1K.   Election of Director: James Quincey   Management   For   For  
1L.   Election of Director: James C. Smith   Management   For   For  
2.   Ratify the selection of KPMG LLP as independent registered public accounting firm for 2022   Management   For   For  
3.   2022 advisory approval of executive compensation   Management   For   For  
4.   Shareholder proposal regarding amending proxy access   Shareholder   Against   For  
5.   Shareholder proposal regarding report on political expenditures congruency   Shareholder   Against   For  
6.   Shareholder proposal regarding report on transfer of intellectual property to potential COVID-19 manufacturers   Shareholder   Against   For  
7.   Shareholder proposal regarding report on board oversight of risks related to anticompetitive practices   Shareholder   Against   For  
8.   Shareholder proposal regarding report on public health costs of protecting vaccine technology   Shareholder   Against   For  

 

PHYSICIANS REALTY TRUST

 

Security 71943U104 Meeting Type Annual
Ticker Symbol DOC Meeting Date 03-May-2022
Record Date 24-Feb-2022    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1.1   Election of Trustee: John T. Thomas   Management   For   For  
1.2   Election of Trustee: Tommy G. Thompson   Management   For   For  
1.3   Election of Trustee: Stanton D. Anderson   Management   For   For  
1.4   Election of Trustee: Mark A. Baumgartner   Management   For   For  
1.5   Election of Trustee: Albert C. Black, Jr.   Management   For   For  
1.6   Election of Trustee: William A. Ebinger, M.D.   Management   For   For  
1.7   Election of Trustee: Pamela J. Kessler   Management   For   For  
1.8   Election of Trustee: Ava E. Lias-Booker   Management   For   For  
1.9   Election of Trustee: Richard A. Weiss   Management   For   For  
2.   To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2022.   Management   For   For  
3.   To approve, on a non-binding advisory basis, the compensation paid to the Company's named executive officers.   Management   For   For  
4.   To approve, on a non-binding advisory basis, the frequency of casting future votes on the compensation paid to the Company's named executive officers.   Management   1 Year   For  

 

 

 

 

R1 RCM, INC.

 

Security 749397105 Meeting Type Annual
Ticker Symbol RCM Meeting Date 26-May-2022
Record Date 06-Apr-2022    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1.   DIRECTOR   Management          
    1. Agnes Bundy Scanlan       For   For  
    2. David M. Dill       For   For  
    3. Michael C. Feiner       For   For  
    4. Joseph Flanagan       For   For  
    5. John B. Henneman III       For   For  
    6. Neal Moszkowski       For   For  
    7. Ian Sacks       For   For  
    8. Jill Smith       For   For  
    9. Anthony J. Speranzo       For   For  
    10. Anthony R. Tersigni       For   For  
    11. Albert R. Zimmerli       For   For  
2.   To approve, for purposes of complying with the applicable provisions of Nasdaq Listing Rule 5635, the issuance of shares of common stock of Project Roadrunner Parent Inc. ("New R1") to CoyCo 1, L.P. and CoyCo 2, L.P., pursuant to the terms of the Transaction Agreement and Plan of Merger, dated as of January 9, 2022, by and among the Company, New R1, Project Roadrunner Merger Sub Inc., Revint Holdings, LLC ("Cloudmed"), CoyCo 1, L.P., CoyCo 2., L.P., and certain other parties, as described in the accompanying proxy statement/prospectus.   Management   For   For  
3.   To approve the adoption of an amendment to the Company's Restated Certificate of Incorporation to increase our authorized share capital from 500,000,000 shares to 750,000,000 shares of common stock.   Management   For   For  
4.   To ratify the selection of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2022.   Management   For   For  
5.   To approve the adjournment of the 2022 Annual Meeting to a later date, or dates, if necessary, to permit further solicitation and vote of proxies in the event that there are insufficient votes for the approval of one or more proposals at the 2022 Annual Meeting.   Management   For   For  

 

RALLYBIO CORPORATION

 

Security 75120L100 Meeting Type Annual
Ticker Symbol RLYB Meeting Date 24-May-2022
Record Date 30-Mar-2022    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1.1   Election of Class I Director: Martin W. Mackay   Management   For   For  
1.2   Election of Class I Director: Kush M. Parmar   Management   For   For  
1.3   Election of Class I Director: Paula Soteropoulos   Management   For   For  
2.   Ratification of the appointment of Deloitte & Touche LLP as the independent registered public accounting firm.   Management   For   For  

 

 

 

 

REGENERON PHARMACEUTICALS, INC.

 

Security 75886F107 Meeting Type Annual
Ticker Symbol REGN Meeting Date 10-Jun-2022
Record Date 12-Apr-2022    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1a.   Election of Director: Bonnie L. Bassler, Ph.D.   Management   For   For  
1b.   Election of Director: Michael S. Brown, M.D.   Management   For   For  
1c.   Election of Director: Leonard S. Schleifer, M.D., Ph.D.   Management   For   For  
1d.   Election of Director: George D. Yancopoulos, M.D., Ph.D.   Management   For   For  
2.   Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2022.   Management   For   For  
3.   Proposal to approve, on an advisory basis, executive compensation.   Management   For   For  

 

RESMED, INC.

 

Security 761152107 Meeting Type Annual
Ticker Symbol RMD Meeting Date 18-Nov-2021
Record Date 21-Sep-2021    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1A.   Re-election of Director to serve until 2022 annual meeting: Karen Drexler   Management   For   For  
1B.   Re-election of Director to serve until 2022 annual meeting: Michael Farrell   Management   For   For  
1C.   Re-election of Director to serve until 2022 annual meeting: Peter Farrell   Management   For   For  
1D.   Re-election of Director to serve until 2022 annual meeting: Harjit Gill   Management   For   For  
1E.   Re-election of Director to serve until 2022 annual meeting: Ron Taylor   Management   For   For  
1F.   Election of Director to serve until 2022 annual meeting: John Hernandez   Management   For   For  
1G.   Election of Director to serve until 2022 annual meeting: Desney Tan   Management   For   For  
2.   Ratify our selection of KPMG LLP as our independent registered public accounting firm for the fiscal year ending June 30, 2022.   Management   For   For  
3.   Approve, on an advisory basis, the compensation paid to our named executive officers, as disclosed in the proxy statement ("say-on-pay").   Management   For   For  

 

 

 

 

SABRA HEALTH CARE REIT, INC.

 

Security 78573L106 Meeting Type Annual
Ticker Symbol SBRA Meeting Date 14-Jun-2022
Record Date 18-Apr-2022    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1a.   Election of Director: Craig A. Barbarosh   Management   For   For  
1b.   Election of Director: Katie Cusack   Management   For   For  
1c.   Election of Director: Michael J. Foster   Management   For   For  
1d.   Election of Director: Lynne S. Katzmann   Management   For   For  
1e.   Election of Director: Ann Kono   Management   For   For  
1f.   Election of Director: Jeffrey A. Malehorn   Management   For   For  
1g.   Election of Director: Richard K. Matros   Management   For   For  
1h.   Election of Director: Clifton J. Porter II   Management   For   For  
2.   Ratification of the appointment of PricewaterhouseCoopers LLP as Sabra's independent registered public accounting firm for the fiscal year ending December 31, 2022.   Management   For   For  
3.   Approval, on an advisory basis, of the compensation of Sabra's named executive officers.   Management   For   For  

 

SAREPTA THERAPEUTICS, INC.

 

Security 803607100 Meeting Type Annual
Ticker Symbol SRPT Meeting Date 02-Jun-2022
Record Date 08-Apr-2022    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1.1   Election of Class I Director to hold office until the 2024 Annual meeting: Kathryn Boor, Ph.D.   Management   For   For  
1.2   Election of Class I Director to hold office until the 2024 Annual meeting: Michael Chambers   Management   For   For  
1.3   Election of Class I Director to hold office until the 2024 Annual meeting: Douglas S. Ingram   Management   For   For  
1.4   Election of Class I Director to hold office until the 2024 Annual meeting: Hans Wigzell, M.D., Ph.D.   Management   For   For  
2.   To hold an advisory vote to approve, on a non-binding basis, named executive officer compensation.   Management   For   For  
3.   To approve an amendment to the Company's 2018 Equity Incentive Plan (the "2018 Plan") to increase the maximum aggregate number of shares of common stock that may be issued pursuant to awards granted under the 2018 Plan by 2,500,000 shares to 10,687,596 shares.   Management   For   For  
4.   To ratify the selection of KPMG LLP as the Company's independent registered public accounting firm for the current year ending December 31, 2022.   Management   For   For  

 

 

 

 

SEAGEN, INC.

 

Security 81181C104 Meeting Type Annual
Ticker Symbol SGEN Meeting Date 13-May-2022
Record Date 17-Mar-2022    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1A.   Election of Class III Director: Ted W. Love, M.D.   Management   For   For  
1B.   Election of Class III Director: Daniel G. Welch   Management   For   For  
2.   Approve, on an advisory basis, the compensation of Seagen's named executive officers as disclosed in the accompanying proxy statement.   Management   For   For  
3.   Ratify the appointment of PricewaterhouseCoopers LLP as Seagen's independent registered public accounting firm for the fiscal year ending December 31, 2022.   Management   For   For  

 

STERIS PLC

 

Security G8473T100 Meeting Type Annual
Ticker Symbol STE Meeting Date 29-Jul-2021
Record Date 01-Jun-2021    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1A.   Re-election of Director: Richard C. Breeden   Management   For   For  
1B.   Re-election of Director: Daniel A. Carestio   Management   For   For  
1C.   Re-election of Director: Cynthia L. Feldmann   Management   For   For  
1D.   Re-election of Director: Christopher Holland   Management   For   For  
1E.   Re-election of Director: Dr. Jacqueline B. Kosecoff   Management   For   For  
1F.   Re-election of Director: Paul E. Martin   Management   For   For  
1G.   Re-election of Director: Dr. Nirav R. Shah   Management   For   For  
1H.   Re-election of Director: Dr. Mohsen M. Sohi   Management   For   For  
1I.   Re-election of Director: Dr. Richard M. Steeves   Management   For   For  
2.   To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending March 31, 2022.   Management   For   For  
3.   To appoint Ernst & Young Chartered Accountants as the Company's Irish statutory auditor under the Act to hold office until the conclusion of the Company's next Annual General Meeting.   Management   For   For  
4.   To authorize the Directors of the Company or the Audit Committee to determine the remuneration of Ernst & Young Chartered Accountants as the Company's Irish statutory auditor.   Management   For   For  
5.   To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers as disclosed pursuant to the disclosure rules of the Securities and Exchange Commission, including the Compensation Discussion and Analysis and the tabular and narrative disclosure contained in the Company's proxy statement dated June 14, 2021.   Management   For   For  

 

 

 

 

STRYKER CORPORATION

 

Security 863667101 Meeting Type Annual
Ticker Symbol SYK Meeting Date 04-May-2022
Record Date 07-Mar-2022    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1A)   Election of Director: Mary K. Brainerd   Management   For   For  
1B)   Election of Director: Giovanni Caforio, M.D.   Management   For   For  
1C)   Election of Director: Srikant M. Datar, Ph.D.   Management   For   For  
1D)   Election of Director: Allan C. Golston (Lead Independent Director)   Management   For   For  
1E)   Election of Director: Kevin A. Lobo (Chair of the Board, Chief Executive Officer and President)   Management   For   For  
1F)   Election of Director: Sherilyn S. McCoy   Management   For   For  
1G)   Election of Director: Andrew K. Silvernail   Management   For   For  
1H)   Election of Director: Lisa M. Skeete Tatum   Management   For   For  
1I)   Election of Director: Ronda E. Stryker   Management   For   For  
1J)   Election of Director: Rajeev Suri   Management   For   For  
2)   Ratification of Appointment of our Independent Registered Public Accounting Firm.   Management   For   For  
3)   Advisory Vote to Approve Named Executive Officer Compensation.   Management   For   For  
4)   Shareholder Proposal to Amend Proxy Access Terms.   Shareholder   Against   For  

 

SYNEOS HEALTH, INC.

 

Security 87166B102 Meeting Type Annual
Ticker Symbol SYNH Meeting Date 25-May-2022
Record Date 28-Mar-2022    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1A.   Election of Director: Todd M. Abbrecht   Management   For   For  
1B.   Election of Director: John M. Dineen   Management   For   For  
1C.   Election of Director: William E. Klitgaard   Management   For   For  
1D.   Election of Director: David S. Wilkes, M.D.   Management   For   For  
2.   To approve an amendment to the Certificate of Incorporation to phase-out the classified board structure and provide that all directors elected at or after the 2025 annual meeting of stockholders be elected on an annual basis.   Management   For   For  
3.   To approve, on an advisory (nonbinding) basis, our executive compensation.   Management   For   For  
4.   To approve, on an advisory (nonbinding) basis, the frequency of future stockholder advisory votes on executive compensation.   Management   1 Year   For  
5.   To ratify the appointment of the Company's independent auditors Deloitte & Touche LLP.   Management   For   For  

 

 

 

 

TEVA PHARMACEUTICAL INDUSTRIES LIMITED

 

Security 881624209 Meeting Type Annual
Ticker Symbol TEVA Meeting Date 23-Jun-2022
Record Date 16-May-2022    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1a.   Election of Director: Amir Elstein   Management   For   For  
1b.   Election of Director: Roberto A. Mignone   Management   For   For  
1c.   Election of Director: Dr. Perry D. Nisen   Management   For   For  
1d.   Election of Director: Dr. Tal Zaks   Management   For   For  
2.   To approve, on a non-binding advisory basis, the compensation for Teva's named executive officers.   Management   For   For  
3.   To approve Teva's Compensation Policy with respect to the Terms of Office and Employment of Teva's Executive Officers and Directors.   Management   For   For  
3A.   Regarding proposal 3, please indicate when you vote whether or not you are a controlling shareholder of Teva and whether or not you have a personal benefit or other interest in this proposal* Mark "for" = yes or "against" = no.   Management   Against   N/A  
4.   To approve amendments to Teva's Articles of Association.   Management   For   For  
5.   To appoint Kesselman & Kesselman, a member of PricewaterhouseCoopers International Ltd., as Teva's independent registered public accounting firm until Teva's 2023 annual meeting of shareholders.   Management   For   For  

 

 

 

 

 

 

THE SELECT SECTOR SPDR TRUST

 

Security 81369Y209 Meeting Type Special
Ticker Symbol XLV Meeting Date 29-Oct-2021
Record Date 03-Sep-2021    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1.   DIRECTOR   Management          
    1. Allison Grant Williams       For   For  
    2. Sheila Hartnett-Devlin       For   For  
    3. James Jessee       For   For  
    4. Teresa Polley       For   For  
    5. Ashley T. Rabun       For   For  
    6. James E. Ross       For   For  
    7. Rory Tobin       For   For  

 

THERMO FISHER SCIENTIFIC, INC.

 

Security 883556102 Meeting Type Annual
Ticker Symbol TMO Meeting Date 18-May-2022
Record Date 25-Mar-2022    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1A.   Election of director: Marc N. Casper   Management   For   For  
1B.   Election of director: Nelson J. Chai   Management   For   For  
1C.   Election of director: Ruby R. Chandy   Management   For   For  
1D.   Election of director: C. Martin Harris   Management   For   For  
1E.   Election of director: Tyler Jacks   Management   For   For  
1F.   Election of director: R. Alexandra Keith   Management   For   For  
1G.   Election of director: Jim P. Manzi   Management   For   For  
1H.   Election of director: James C. Mullen   Management   For   For  
1I.   Election of director: Lars R. Sorensen   Management   For   For  
1J.   Election of director: Debora L. Spar   Management   For   For  
1K.   Election of director: Scott M. Sperling   Management   For   For  
1L.   Election of director: Dion J. Weisler   Management   For   For  
2.   An advisory vote to approve named executive officer compensation.   Management   For   For  
3.   Ratification of the Audit Committee's selection of PricewaterhouseCoopers LLP as the Company's independent auditors for 2022.   Management   For   For  

 

 

 

 

UNITED THERAPEUTICS CORPORATION

 

Security 91307C102 Meeting Type Special
Ticker Symbol UTHR Meeting Date 30-Sep-2021
Record Date 10-Aug-2021    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1.   Approval of an amendment to our Restated Certificate of Incorporation to become a public benefit corporation.   Management   Abstain   Against  

 

UNITED THERAPEUTICS CORPORATION

 

Security 91307C102 Meeting Type Annual
Ticker Symbol UTHR Meeting Date 27-Jun-2022
Record Date 28-Apr-2022    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1a.   Election of Director: Christopher Causey   Management   For   For  
1b.   Election of Director: Richard Giltner   Management   For   For  
1c.   Election of Director: Katherine Klein   Management   For   For  
1d.   Election of Director: Ray Kurzweil   Management   For   For  
1e.   Election of Director: Linda Maxwell   Management   For   For  
1f.   Election of Director: Nilda Mesa   Management   For   For  
1g.   Election of Director: Judy Olian   Management   For   For  
1h.   Election of Director: Martine Rothblatt   Management   For   For  
1i.   Election of Director: Louis Sullivan   Management   For   For  
2.   Advisory resolution to approve executive compensation.   Management   For   For  
3.   Approval of the amendment and restatement of the United Therapeutics Corporation Amended and Restated 2015 Stock Incentive Plan.   Management   For   For  
4.   Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for 2022.   Management   For   For  

 

UNIVERSAL HEALTH REALTY INCOME TRUST

 

Security 91359E105 Meeting Type Annual
Ticker Symbol UHT Meeting Date 08-Jun-2022
Record Date 11-Apr-2022    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1.1   Election of Trustee: Michael Allan Domb   Management   For   For  
1.2   Election of Trustee: James P. Morey   Management   For   For  
2.   Advisory (nonbinding) vote to approve named executive officer compensation.   Management   For   For  
3.   To ratify the selection of KPMG, LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2022.   Management   For   For  

 

 

 

 

UNIVERSAL HEALTH SERVICES, INC.

 

Security 913903100 Meeting Type Annual
Ticker Symbol UHS Meeting Date 18-May-2022
Record Date 24-Mar-2022    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1.   Election of Director: Maria R. Singer   Management   For   For  
2.   Proposal to approve an amendment and restatement of the Company's 2020 Omnibus Stock and Incentive Plan.   Management   For   For  
3.   Proposal to ratify the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2022.   Management   For   For  
4.   Stockholder Proposal regarding majority vote standard in director elections if properly presented at the meeting.   Shareholder   Against   For  

 

UNITEDHEALTH GROUP, INC.

 

Security 91324P102 Meeting Type Annual
Ticker Symbol UNH Meeting Date 06-Jun-2022
Record Date 08-Apr-2022    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1a.   Election of Director: Timothy P. Flynn   Management   For   For  
1b.   Election of Director: Paul R. Garcia   Management   For   For  
1c.   Election of Director: Stephen J. Hemsley   Management   For   For  
1d.   Election of Director: Michele J. Hooper   Management   For   For  
1e.   Election of Director: F. William McNabb III   Management   For   For  
1f.   Election of Director: Valerie C. Montgomery Rice, M.D.   Management   For   For  
1g.   Election of Director: John H. Noseworthy, M.D.   Management   For   For  
1h.   Election of Director: Andrew Witty   Management   For   For  
2.   Advisory approval of the Company's executive compensation.   Management   For   For  
3.   Ratification of the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for the Company for the year ending December 31, 2022.   Management   For   For  
4.   If properly presented at the 2022 Annual Meeting of Shareholders, the shareholder proposal seeking shareholder ratification of termination pay.   Shareholder   Against   For  
5.   If properly presented at the 2022 Annual Meeting of Shareholders, the shareholder proposal regarding political contributions congruency report.   Shareholder   Against   For  

 

 

 

 

 

VENTAS, INC.

 

Security 92276F100 Meeting Type Contested-Annual
Ticker Symbol VTR Meeting Date 27-Apr-2022
Record Date 21-Mar-2022    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1.   DIRECTOR   Management          
    1. Melody C. Barnes       For   For  
    2. Debra A. Cafaro       For   For  
    3. Michael J. Embler       For   For  
    4. Matthew J. Lustig       For   For  
    5. Roxanne M. Martino       For   For  
    6. Marguerite M. Nader       For   For  
    7. Sean P. Nolan       For   For  
    8. Walter C. Rakowich       For   For  
    9. Robert D. Reed       For   For  
    10. James D. Shelton       For   For  
    11. Maurice S. Smith       For   For  
2.   Proposal to approve, on an advisory basis, the compensation of our Named Executive Officers.   Management   For   For  
3.   Proposal to approve the Ventas, Inc. 2022 Incentive Plan.   Management   For   For  
4.   Proposal to ratify KPMG LLP as our independent registered public accounting firm for the 2022 fiscal year.   Management   For   For  

 

VERTEX PHARMACEUTICALS INCORPORATED

 

Security 92532F100 Meeting Type Annual
Ticker Symbol VRTX Meeting Date 18-May-2022
Record Date 24-Mar-2022    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1A.   Election of Director: Sangeeta Bhatia   Management   For   For  
1B.   Election of Director: Lloyd Carney   Management   For   For  
1C.   Election of Director: Alan Garber   Management   For   For  
1D.   Election of Director: Terrence Kearney   Management   For   For  
1E.   Election of Director: Reshma Kewalramani   Management   For   For  
1F.   Election of Director: Yuchun Lee   Management   For   For  
1G.   Election of Director: Jeffrey Leiden   Management   For   For  
1H.   Election of Director: Margaret McGlynn   Management   For   For  
1I.   Election of Director: Diana McKenzie   Management   For   For  
1J.   Election of Director: Bruce Sachs   Management   For   For  
1K.   Election of Director: Suketu Upadhyay   Management   For   For  
2.   Ratification of Ernst & Young LLP as independent Registered Public Accounting firm for the year ending December 31, 2022.   Management   For   For  
3.   Advisory vote to approve named executive office compensation.   Management   For   For  
4.   Approval of an amendment and restatement of our 2013 Stock and Option Plan to increase the number of shares authorized for issuance under this plan by 13.5 million shares.   Management   For   For  

 

 

 

WATERS CORPORATION

 

Security 941848103 Meeting Type Annual
Ticker Symbol WAT Meeting Date 24-May-2022
Record Date 25-Mar-2022    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1.1   Election of Director: Dr. Udit Batra, Ph.D.   Management   For   For  
1.2   Election of Director: Linda Baddour   Management   For   For  
1.3   Election of Director: Edward Conard   Management   For   For  
1.4   Election of Director: Dr. Pearl S. Huang, Ph.D.   Management   For   For  
1.5   Election of Director: Wei Jiang   Management   For   For  
1.6   Election of Director: Christopher A. Kuebler   Management   For   For  
1.7   Election of Director: Dr. Flemming Ornskov, M.D., M.P.H.   Management   For   For  
1.8   Election of Director: Thomas P. Salice   Management   For   For  
2.   To ratify the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2022.   Management   For   For  
3.   To approve, by non-binding vote, executive compensation.   Management   For   For  

 

WELLTOWER, INC.

 

Security 95040Q104 Meeting Type Annual
Ticker Symbol WELL Meeting Date 23-May-2022
Record Date 04-Apr-2022    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1A.   Election of Director: Kenneth J. Bacon   Management   For   For  
1B.   Election of Director: Karen B. DeSalvo   Management   For   For  
1C.   Election of Director: Philip L. Hawkins   Management   For   For  
1D.   Election of Director: Dennis G. Lopez   Management   For   For  
1E.   Election of Director: Shankh Mitra   Management   For   For  
1F.   Election of Director: Ade J. Patton   Management   For   For  
1G.   Election of Director: Diana W. Reid   Management   For   For  
1H.   Election of Director: Sergio D. Rivera   Management   For   For  
1I.   Election of Director: Johnese M. Spisso   Management   For   For  
1J.   Election of Director: Kathryn M. Sullivan   Management   For   For  
2.   To amend the Certificate of Incorporation of Welltower OP Inc. to remove the provision requiring Welltower Inc. shareholders to approve amendments to the Welltower OP Inc. Certificate of Incorporation and other extraordinary transactions involving Welltower OP Inc.   Management   For   For  
3.   The ratification of the appointment of Ernst & Young LLP as independent registered public accounting firm for the year ending December 31, 2022.   Management   For   For  
4.   The approval, on an advisory basis, of the compensation of our named executive officers as disclosed in the 2022 Proxy Statement.   Management   For   For  

 

 

 

ZIMMER BIOMET HOLDINGS, INC.

 

Security 98956P102 Meeting Type Annual
Ticker Symbol ZBH Meeting Date 13-May-2022
Record Date 14-Mar-2022    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1A.   Election of Director: Christopher B. Begley   Management   For   For  
1B.   Election of Director: Betsy J. Bernard   Management   For   For  
1C.   Election of Director: Michael J. Farrell   Management   For   For  
1D.   Election of Director: Robert A. Hagemann   Management   For   For  
1E.   Election of Director: Bryan C. Hanson   Management   For   For  
1F.   Election of Director: Arthur J. Higgins   Management   For   For  
1G.   Election of Director: Maria Teresa Hilado   Management   For   For  
1H.   Election of Director: Syed Jafry   Management   For   For  
1I.   Election of Director: Sreelakshmi Kolli   Management   For   For  
1J.   Election of Director: Michael W. Michelson   Management   For   For  
2.   Ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for 2022.   Management   For   For  
3.   Approve, on a non-binding advisory basis, named executive officer compensation ("Say on Pay").   Management   For   For  

 

ZOETIS, INC.

 

Security 98978V103 Meeting Type Annual
Ticker Symbol ZTS Meeting Date 19-May-2022
Record Date 25-Mar-2022    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1A.   Election of Director: Paul M. Bisaro   Management   For   For  
1B.   Election of Director: Frank A. D'Amelio   Management   For   For  
1C.   Election of Director: Michael B. McCallister   Management   For   For  
2.   Advisory vote to approve our executive compensation.   Management   For   For  
3.   Approval of an Amendment and Restatement of our 2013 Equity and Incentive Plan.   Management   For   For  
4.   Ratification of appointment of KPMG LLP as our independent registered public accounting firm for 2022.   Management   For   For  
5.   Approval of an amendment to our Restated Certificate of Incorporation to eliminate supermajority voting provisions and certain provisions related to Pfizer Inc.   Management   For   For  
6.   Approval of an amendment to our Restated Certificate of Incorporation to declassify the Board of Directors.   Management   For   For  

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

(Registrant) Tekla Healthcare Opportunites Fund  
     
By (Signature and Title)*      
     
  /s/ Daniel R. Omstead  
  (Daniel R. Omstead, President)  
     
Date 8/19/22  
         

 

 

*Print the name and title of each signing officer under his or her signature.

 

 

abrdn Healthcare Opportu... (NYSE:THQ)
Historical Stock Chart
Von Mär 2024 bis Apr 2024 Click Here for more abrdn Healthcare Opportu... Charts.
abrdn Healthcare Opportu... (NYSE:THQ)
Historical Stock Chart
Von Apr 2023 bis Apr 2024 Click Here for more abrdn Healthcare Opportu... Charts.